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The explosion of high throughput genomic data in recent years has already altered 
our view of the extent and complexity of biology. In the past decade, microarray 
technology (1) has played a prominent role in advancing our understanding of 
transcriptome complexity. Microarray is a hybridization-based technology that incubates 
fluorescently- labeled cDNA with custom-made microarray or commercial GeneChips. 
Microarray allowed scientists to simultaneously monitor the expression of almost all the 
genes in the genome, and along with a steady reduction in processing costs, led to its 
wide spread application. ChIP-chip (2), a technology that combines chromatin 
immunoprecipitation with microarray, has been widely utilized to investigate interactions 
between proteins and DNA in vivo. In ChIP-chip experiments, the protein-DNA binding 
is recognized by detecting hybridization signals using a fixed set of probes on DNA 
microarrays. However, due to their restriction of the probes present on the DNA 
microarray, such methods are naturally limited in scale and resolution.  Whole-genome 




 With the recent development of next generation sequencing, array-based 
technologies have being replaced by sequencing-based technologies, such as RNA-Seq (3) 
and ChIP-Seq (4), which can dramatically improve the quantity and quality of high 
throughput genomic data. In RNA-Seq experiments, a population of RNA is converted to 
a library of cDNA fragments with adaptors attached to one end. Each molecule, after 
amplification, is then sequenced using next generation sequencing technologies. 
Following sequencing, the resulting reads are aligned to either the reference geno me or 
known transcripts to produce a genome-scale transcriptional profile. Meanwhile, ChIP-
Seq, or chromatin immunoprecipitation followed by ultra-high- throughput sequencing, 
has emerged as a powerful new technology for genome-wide mapping of protein-DNA 
interactions and histone modifications. Through direct sequencing of all DNA fragment 
from ChIP assays, ChIP-Seq is capable of revealing protein-DNA interaction sites across 
the entire genome, thus building a comprehensive and high-resolution interactome map 
for DNA-binding proteins of interest.  The comprehensiveness and the high resolution are 
two key advantages of ChIP-Seq over ChIP-chip. 
To analyze such high throughput genomic data is complicated. While sequencing 
cost has significantly declined, the amount of data the new platforms produce is 
skyrocketing, thereby producing an analytical bottleneck. Detecting biological signals 
from experimental noises is similar to looking for a needle in a haystack. Technologically 
specific features, heterogeneous data structures and massive sample sizes present great 





Several analytical modalities have been proposed for analyzing high throughput 
genomic data, such as Boolean networks (5), gene networks (6) and genetic algorithms 
(7). A majority of them are frequentist modeling methods which involve complicated 
inference procedure and unstable numerical implementation. In this context, a Bayesian 
modeling method appears to be an attractive alternative. 
In this dissertation, we describe three Bayesian modeling methods in high throughput 
genomic data analysis. The general Bayesian modeling procedure can be described as 
consisting of two main steps (8): (a) setting up a full probability model, the joint 
distribution , that captures the relationship among all the variables (e.g., observed 
data , unknown parameters ) into consideration; (b) summarizing the findings for 
particular quantities of interest using appropriate posterior distributions, which is 
typically a conditional distribution of the quantities of interest given the observed data.  
A standard procedure for carrying out step (a) is to formulate the scientific question 
of interest though the use of a probabilistic model from which we can write down the 
likelihood function of unknown parameters. In the analysis of high throughput genomic 
data, this step involves understanding the underlying biological process and the data 
generation mechanism. Then a prior distribution  is contemplated, which should be 
both mathematically tractable and scientifically meaningful. Usually  is derived 
from previous biological findings. The joint probability distribution can then be 
represented as the product of the likelihood and the prior . Step (b) 






After integrating out nuisance parameters, we get full conditional distribution of 
unknown parameter  and conduct the standard posterior sampling based inference via 
Markov Chain Monte Carlo techniques.  
The Bayesian modeling approach has at least two advantages in analyzing high 
throughput genomic data. First, through the prior distribution, we can use prior 
knowledge and information about the value of unknown parameters. This is especially 
important since biologists often have substantial knowledge about the subject under study. 
To the extent that this information is correct, it will sharpen the inference about the 
unknown parameters and accelerate the detection of biological signals. Second, treating 
all the variables in the system as random variables greatly clarifies the methods of 
analysis. It follows from the basic probability theory (Bayes formula) that information 
about the realized value of any random variable based on observation of related random 
variables is summarized in the conditional distribution.  
1.2 Outline  
This thesis consists of three chapters that each addresses an independent statistical 
problem in high throughput genomic data analysis.  
In chapter 2, we develop a querying algorithm for analyzing microarray compendium 
data (9). In microarray gene expression data analysis, it is often of interest to identify 
genes that share similar expression profiles with a particular gene such as a key 
regulatory protein. While working well for small datasets, the heterogeneity introduced 




approaches. This is because most co-expression relationships do not extend to all 
experimental conditions. With the rapid increase in the size of microarray datasets, 
identifying functionally related genes from large and diverse microarray gene expression 
datasets is a key challenge. We develop a model-based gene expression query algorithm 
built under the Bayesian model selection framework that is capable of detecting co-
expression profiles under a subset of samples/experimental conditions. In addition, this 
algorithm allows linearly transformed expression patterns to be recognized and is robust 
against sporadic outliers in the data. Both features are critically important for increasing 
the power of identifying co-expressed genes in large scale gene expression datasets. Our 
simulation studies suggest that this method outperforms existing correlation coefficients 
or mutual information-based query tools. When we apply this new method to the 
Escherichia coli microarray compendium data, it identifies a majority of known regulons, 
as well as novel potential target genes of numerous key transcription factors.  
In chapter 3, we study the de novo motif finding problem using ChIP-Seq data (10). 
Coupling chromatin immunoprecipitation (ChIP) with recently developed massively 
parallel sequencing technologies has enabled genome-wide detection of protein–DNA 
interactions with unprecedented sensitivity and specificity. This new technology, ChIP-
Seq, presents opportunities for in-depth analysis of transcription regulation. In this study, 
we explore the value of using ChIP-Seq data to better detect and refine transcription 
factor binding sites (TFBS). We introduce a novel computational algorithm named 
Hybrid Motif Sampler (HMS), specifically designed for TFBS motif discovery in ChIP-
Seq data. We propose a Bayesian model that incorporates sequencing depth information 




more accurately the underlying motif pattern. Our algorithm combines stochastic 
sampling and deterministic comprehensive search steps into a novel hybrid iterative 
scheme. This combination accelerates the computation process. Simulation studies 
demonstrate favorable performance of HMS compared  to other existing methods. When 
applying HMS to real ChIP-Seq datasets, we find that (i) the accuracy of existing TFBS 
motif patterns can be significantly improved; and (ii) there is significant intra-motif 
dependency inside all the TFBS motifs we tested; modeling these dependencies further 
improves the accuracy of these TFBS motif patterns. These findings may offer new 
biological insights into the mechanisms of transcription factor regulation.  
In chapter 4, we design a model-based gene expression measurement using RNA-
Seq data. High throughput sequencing technology, also called RNA-Seq, has become a 
revolutionary tool for transcriptomics analysis. Compared to microarray, RNA-Seq offers 
clear advantages, such as better dynamic range and the ability to discover novel 
transcripts. Current methods enumerate the number of reads within each exon and use the 
normalized read counts to represent the gene expression levels for that exon. However, 
the sequencing depth across exons fluctuates substantially and shows significant spatial 
correlation. These variations will affect the simple enumeration method that is currently 
being used. In this study, we propose a spatial Poisson regression model to provide a 
portrait of base- level sequencing depth within each exon. This method can capture local 
genomic features that affect coverage depth in the spatial model, and therefore, offer 





CHAPTER 2  
 
Query large scale microarray compendium datasets using a model-based Bayesian 




Genome-wide expression analysis with DNA microarray technology (1),(11). has 
become an indispensable tool in genomics research (12). Increased accessibility, lowered 
cost and improved technology result in more comprehensive studies, under more diverse 
conditions and a rapid expansion of available gene expression data. This presents an 
important resource for mining biological information. A particular example is the so-
called microarray compendium in which gene expression profiles were surveyed in 
hundreds of samples which were treated under diverse biological conditions (13-15). 
Data generated from such studies is highly informative. However, due to heterogeneity, 
finding biological insight from such datasets proves a major challenge. Scalable and 
effective mining tools capable of extracting knowledge from diverse and noisy 
information sources are critically needed (16). 
 An effective data mining tool for gene expression microarray data is to infer 
relatedness among genes based on their expression profile, a tactic referred to as the 




functionally related genes, such as transcription factor (TF) and its regulated genes—
regulon —tend to display correlated gene expression patterns. For example, Mootha et al. 
(2003) (22) proposed the "neighborhood analysis algorithm" to identify "neighboring" 
genes that share correlated expression profiles with genes of interest. Various 
measurements such as Pearson correlation, Spearman’s rank correlation, Kendall’s  and 
mutual information (23) have been used to assess the strength of the correlation. 
Recently, much interest has been generated on genome-wide regulatory network 
inference (24), where pairwise regulatory relationships among genes need to be 
predicted. As an example, Faith et al. (2007) (13) developed the context likelihood of 
relatedness (CLR) algorithm to identify regulatory interactions.  
 Although successful in analyzing small datasets, the above mentioned correlation 
or distance measures will be less helpful for searching large datasets, such as microarray 
compendium data. This is because for most functionally related genes, tight correlation 
only occurs under specific experimental conditions. Therefore global correlation 
measures taken across diverse experimental conditions will be significantly reduced, and 
thus make it harder to recognize functional related genes. Given the microarray 
compendium scenario, we hypothesized that statistically significant correlation can still 
be detected using microarray, but strong correlation will be confined to a subset of 
samples/experimental conditions. Under this hypothesis, it is highly desirable to develop 
a query tool that can automatically recognize a subset of conditions under which the 
query gene and its targets share tightly correlated expression profiles. This is analogous 
to the development of local alignment tools such as BLAST (25) to search for subtle 




 In this study, we design a model-based query algorithm capable of detecting 
significantly correlated expression patterns that are restricted to a subset of experimental 
conditions. See Figure 2.1 for an illustration of our scheme. This approach not only 
predicts functionally related genes, it also allows one to discover under which 
experimental conditions such co-expression occurs. The proposed query tool will provide 
researchers with a much needed device to explore the rich resources of vast microarray 
databases available. This model is inspired by the Bayesian Partition with Pattern 
Selection (BPPS) model designed to identify functionally related proteins (26). Our 
proposed method is related to bi-clustering (27-31) since we consider both genes and 
samples/experimental conditions. However, bi-clustering is unsupervised, which is 
different from the supervised pattern matching procedure we propose. Qian et al. (2001) 
(32) introduced a pairwise query algorithm for gene expression data based on a Smith-
Waterman type local alignment algorithm (33). However, that algorithm is designed for 
querying time-course gene expression data only, and is generally not applicable to 
datasets where the experimental conditions are unrelated. Dhollander et al. (2007) (34) 
introduced a model-based query-driven module discovery tool—QDB, but it is aimed at 
performing informed bi-clustering instead of pattern matching, and it does not take into 
account the complex correlation patterns such as inverse patterns. Owen et al. (2003) (35) 
proposed a score-based search algorithm called gene recommender (GR) to find genes 
that are co-expressed with a given set of genes using data from large microarray datasets. 
GR first selects a subset of experiments in which the query genes are most strongly co-





Figure 2.1 Illustration of the model-based gene expression query algorithm. Each row 
represents a gene, and each column represents a sample/experimental condition. The 
query gene is at the bottom. The Blue boxes indicate the collection of genes and 













2.2 Methods  
2.2.1 Statistics model 
We propose a model-based query tool for gene expression data. The goal is to 
identify genes that share correlated expression profiles with a particular gene such as a 
key TF. 
The entire microarray compendium can be represented as a matrix, where each 
row represents a gene and each column represents an experimental condition. We are 
hoping to identify a subset of rows (genes) and a subset of columns (conditions) such that 
these genes show co-expression with the query gene under the selected conditions. This 
procedure is similar to placing binary labels on all rows and columns. Finding the 
maximum likelihood estimator is often a good solution to such a statistical inference 
problem. However, the large number of rows and columns make it impossible for us to 






enumerate all possible combinations. We therefore employ a Markov Chain Monte Carlo 
strategy to guide an efficient search. The statistical model and computational algorithm is 
as follows (more details can be found in the appendix). 
Suppose there is a database containing expression levels of N genes across M 
different experimental conditions. Each gene is represented by an expression vector 
 that can be summarized as a data matrix , 
Given a particular query expression profile , we want to identify all 
genes that share similar expression patterns across a subset of experimental conditions. 
To do this, we define a difference vector as , and 
use  as the input data for our inference. We introduce a row indicator 
vector  and a column indicator vector ,  
indicates that gene  in the database is functionally related to the query gene and 0 
otherwise.  indicates that co-expression occurs at the  th experimental condition 
(foreground) and 0 otherwise (background). We assume that the differences between a 
related gene and the query gene at the foreground columns follow normal distributions 
. The remainder of Z is assumed to follow background normal distributions 
where . Let  represents the probability density 
function of normal distribution with mean  and variance . The overall likelihood can 
be expressed as: 
                                                                                                                                          
 
 (2.1) 
where Θ = ( ,  …, , , , … , , , … ). We adopt standard 









                                                                                                                                          
 
 (2.2) 
Specification of these prior distributions can be found in the appendix.  
 Parameters of interest are the two indicator vectors  and .  is regarded as the 
nuisance parameter and is integrated out to simplify the computation (36). We use the 
Gibbs sampler (37,38) to sample  and  from the posterior distributions. To be specific, 
our algorithm will cycle through all rows and columns sequentially, flip the indicator 
variables of each row or column, and then decide whether to accept the change based on 
the Bayes factor calculated. The joint distributions can be derived as follows:  
                                                                                                                                          
 
 (2.3) 
After integrating out nuisance parameters, we get full conditional distributions of 
 and , which are Bernoulli distributions. The details can be found in the appendix.  
The detailed procedure of our algorithm is as follows.  
(1) Initialization: randomly assign row and column indicators to be either one or 




(2) Cycle through all rows and columns sequentially 50 times. At each cycle, 
draw the indicator for each row and column from the full conditional distributions. The 
result with the highest log likelihood during the 50 cycles is recorded.  
(3) Repeat the cycle ten times, and report the result with the highest log likelihood 
from all runs. 
In the initialization step, the row and column indicators can be assigned randomly. 
In practice, one can simply assign 1 to the top half of rows and to the first half of columns 
and 0 to the rest of rows and columns. If there is additional information suggesting 
certain genes (rows) are targets (or non-targets) of the TF, it is recommended that the 
indicator 1 (or 0) be assigned to those genes and the same for the experimental 
conditions. 
2.2.2 Add linear factor 
 In the previous model, we require that the target genes and the query gene share 
similar expression levels in selected experimental conditions. This is restrictive since 
functionally related genes may display the same expression pattern but differ in absolute 
quantity. To capture this, we extend our model to allow the expression levels of the target 
gene and the query gene to differ by a constant factor. That is, their expression profiles 
are proportional to each other: . Here  is a linear transformation factor for 
gene .  can be either positive or negative indicating positive or negative correlation 
respectively. After normalization, we estimate the linear transformation factor  using 
least square without intercept. To keep our model simple and avoid over-fitting, we 
restrict the linear factor to be significantly different from 0. The estimation step is made 




2.2.3 Allow cell-level noise 
 In the aforementioned models, genes selected are mandated to have similar 
expression profiles up to a constant factor under a subset of experimental conditions. 
Hence the chosen rows and columns in the original data matrix form a solid block when 
combined. This may still be too restrictive because a few sporadic cells in the block may 
deviate from the corresponding values in the query profile. Possible reasons that may 
cause such discrepancy are experimental artifacts, measurement errors, or substructures 
in the co-expression pattern. To account for this, we introduce an additional binary 
indicator variable, , for each cell in this block to indicate whether this particular 
gene/experimental condition combination should be treated as background. This 
additional step allows us to identify significant but imperfect patterns. Adding this 
additional parameter, the overall likelihood is modified as follows:  
                                                                                                                                          
 
 (2.4) 
We use a Bernoulli distribution as the prior for ,  
                                                                                                                                          
 
, (2.5) 
 The prior for this new indicator variable will be set such that only a small fraction 
of cells is allowed to be treated as background.  
 After integrating out nuisance parameters, the full conditional distributions of all 






 The aforementioned algorithm has been implemented in a C++ program named 
BEST (Bayesian Expression Search Tool). To test its performance, we applied it to a 
series of synthetic datasets as well as to the real Escherichia coli microarray compendium 
dataset (39). In addition to BEST, we also tested well-established query tools based on 
Pearson, Spearman correlation coefficients, Kendall’s , mutual information (23) and the 
model-based query-driven module discovery tool—QDB (34).  
2.3.1 Synthetic datasets 
 All simulated data contained 100 rows (genes) and 50 columns (experimental 
conditions). Around 20% of the 100 genes were randomly assigned as the "target" genes. 
Let T represent the total number of target genes in a dataset. To mimic the scenarios that 
gene expression correlation only presents in a subset of experimental conditions, we 
separated the 50 columns into foreground and background and require that correlated 
expression profiles between the query gene and the target genes can only be observed 
among foreground columns. To assess the impact of the proportion of foreground 
columns on the effectiveness of identifying target genes, we tested four different settings: 
100%, 75%, 50% and 25% of columns were selected as foreground. At each foreground 
column, the expression profiles of the query gene and  target genes were generated from 
a dimensional multivariate normal distribution with mean zero and variance-
covariance matrix . The correlation coefficient between the query gene and each target 
gene was set to be 0.95. 
 The remaining expression profiles were generated independently from a uniform 




included the following additional settings: randomly add linear transformations to 50% of 
the target genes (the linear transformation factors were randomly picked from 
; randomly add additional noise  to 10% of the expression values of 
target genes in foreground columns to mimic outliers caused by experimental artifacts. 
We also considered settings in which neither or both of these two complications were 
present. The combination of these four scenarios with the four different proportions of 
foreground columns mentioned above resulted in 16 different testing cases. We generated 
50 simulated datasets for each of the 16 cases, and tested all query methods on each 
dataset to identify target genes. To compare performance, we sorted the 100 genes using 
the relatedness measures adopted in each method and found the proportions of true 
positives among the top  genes. The means and standard deviations of these proportions 
were summarized in Table 2.1. We also produced Receiver Operating Characteristic 
(ROC) curves for all methods under all simulation settings. ROC curves obtained from 
the most challenging scenario, where only 25% of the columns are foreground, are shown 
in Figure 2.2. ROC curves obtained from other simulation settings can be found in 
Figures A2.1, A2.2 and A2.3 in appendix. The areas under the curve (AUC) of these 






Table 2.1 Performance comparison among various methods for querying simulated microarray gene expression dataset. Best results 
are displayed in bold.  
 
Case Sub-case* Pearsona Spearmanb Kendallc QDBd  Mutuale  BEST Af BEST Bg BEST Ch 
Case 1: I 1 (0)1 1 (0) 1 (0) 1 (0) 1 (0) 1 (0) 1 (0) 1 (0) 
100% II 0.67 (0.12) 0.68 (0.12) 0.68 (0.12) 0.59 (0.13) 1 (0.01) 1 (0) 1 (0) 1 (0) 
foreground III 1 (0) 1 (0) 1 (0) 1 (0) 1 (0) 1 (0) 1 (0) 1 (0) 
  IV 0.62 (0.09) 0.70 (0.09) 0.70 (0.09) 0.51 (0.11) 0.78 (0.08) 0.97 (0.04) 0.98 (0.03) 0.98 (0.03) 
Case 2: I 0.89 (0.10) 0.96 (0.05) 0.99 (0.03) 1 (0) 0.87 (0.09) 1 (0) 1 (0) 1 (0) 
75% II 0.66 (0.12) 0.71 (0.10) 0.70 (0.09) 0.70 (0.10) 0.81 (0.09) 1 (0) 1 (0) 1 (0) 
foreground III 0.91 (0.09) 0.97 (0.04) 0.99 (0.03) 1 (0) 0.87 (0.09) 1 (0) 1 (0) 1 (0) 
  IV 0.61 (0.11) 0.68 (0.11) 0.70 (0.11) 0.53 (0.12) 0.70 (0.11) 0.97 (0.04) 0.97 (0.04) 0.97 (0.04) 
Case 3: I 0.66 (0.17) 0.73 (0.14) 0.80 (0.13) 0.97 (0.16) 0.61 (0.14) 1 (0) 1 (0) 1 (0) 
50% II 0.51 (0.11) 0.59 (0.11) 0.62 (0.12) 0.71 (0.13) 0.52 (0.13) 1 (0) 1 (0) 1 (0) 
foreground III 0.63 (0.14) 0.70 (0.13) 0.77 (0.12) 0.91 (0.25) 0.59 (0.15) 1 (0) 1 (0) 1 (0) 
  IV 0.42 (0.12) 0.49 (0.12) 0.53 (0.11) 0.53 (0.17) 0.43 (0.16) 0.92 (0.06) 0.92 (0.06) 0.93 (0.05) 
Case 4: I 0.36 (0.13) 0.38 (0.12) 0.40 (0.12) 0.29 (0.29) 0.29 (0.13) 0.79 (0.34) 0.95 (0.15) 1 (0) 
25% II 0.25 (0.10) 0.26 (0.09) 0.28 (0.09) 0.19 (0.08) 0.27 (0.09) 0.73 (0.36) 0.86 (0.28) 0.99 (0.02) 
foreground III 0.34 (0.09) 0.36 (0.09) 0.38 (0.09) 0.21 (0.14) 0.29 (0.10) 0.85 (0.29) 0.95 (0.17) 1 (0) 








1 Performance was measured by the proportions of true positives among the top  genes.  is the number of true positives in each 
simulated dataset. The mean and standard deviation of these proportions in the 50 simulated datasets were reported.  
* There are four sub-cases in each of the simulated cases with the same amount of foreground columns.  
Sub case I: no linear transformation, no cell- level noise; 
Sub case II: only add linear transformation; 
Sub case III: only add cell- level noise; 
Sub case IV: add both linear transformation and cell- level noise. 
a Query method using Pearson correlation coefficient.  
b Query method using Spearman correlation coefficient.  
c Query method using Kendall’s . 
d Query method using QDB. 
e Query method using mutual information. 
f Query method using BEST. 
g Query method using BEST allowing exclusion of individual cells from the foreground.  




Figure 2.2 ROC curves for various query methods when applying to synthetic datasets 
simulated under different settings and when there are 25% foreground columns. BEST A 
default setting; BEST B allowing exclusion of individual cells from the foreground; 
BEST C fixing the indicator variables of five true target genes and five true experimental 
conditions as 1. A. No linear transformation nor cell- level noise. B. With linear 
transformation only. C. With cell- level noise only. D. With both linear transformation 






 From the simulation results, we see that all methods performed perfectly when all 
columns were foreground and no complicated correlation was present. In subsequent 
cases, the performances of all methods deteriorated with the inclusion of background 
columns, linear transformation and additional cell level noise. We observed that BEST is 
robust against added noise and complications and performed the best overall. Even in the 
most challenging case, in which the co-expression only occurred in 25% of the 50 
columns, and half of the co-expressed genes were linearly transformed plus 10% 
additional cell- level noise, BEST still found 57% true co-expressed genes, and the AUC 
was 0.79. The simulation results also indicated that the version of BEST that allows cell-
level noise has 5.4% to 8.2% higher AUCs compared to the version that does not 
consider cell- level noise. To evaluate the impact of incorporating existing knowledge into 
the model, we tested another version of BEST in which we fixed the indicator variables 
of five real target genes and five true foreground experimental conditions as 1. We found 
that in the most challenging case, AUCs further increased 1.0% to 7.6% compared to the 
version that considers cell- level noise. The superior performance of BEST in these 
synthetic datasets suggested that our algorithm worked well in the context of highly 
heterogeneous microarray data and was robust against moderately distorted data and 
sporadic outliers. Our model naturally accommodates existing biological knowledge 
which often results in further improvement in prediction accuracy. Among others, 
sophisticated methods such as QDB and the method based on mutual information 
performed better than the rest as expected. We acknowledge that our simulation scheme 
do not fit QDB well since it is a model-based bi-clustering algorithm not designed for the 




2.3.2 Escherichia dataset 
 This dataset originally came from the study reported in (13). The authors 
conducted a comprehensive survey of gene expression profiles of all E. coli genes using 
612 Affymetrix GeneChip arrays treated with 305 different experimental conditions. The 
goal of that study was to construct regulatory networks and determine the relative merits 
of different network inference algorithms on experimental data. RMA normalized data 
(39) was used in this study. This dataset consisted of 4,217 genes and 305 samples. We 
started with TF Leucine-responsive Regulatory Protein (Lrp) as the query gene. Faith et 
al. (2007) (13) listed Lrp as one of three TFs that show substantial connectivity in the 
network mapped by CLR and recommended it as an ideal test case. The E. coli Lrp is the 
best-studied member of the Lrp family, a global regulator in E. coli affecting the 
expression of many genes and operons (40). According to RegulonDB (41), Lrp has 61 
experimentally verified transcription targets. We refer to the collection of these genes as 
the RegulonDB target set. Faith et al. (2007) (13) predicted potential transcription targets 
of Lrp using CLR, a mutual information-based algorithm. There were 43 genes predicted 
as Lrp targets at 60% precision and one gene was predicted as a Lrp target at 80% 
precision.  
2.3.2.1 Query result from 100-gene test set 
 We tested BEST on this dataset to see if it could identify known target genes of 
Lrp. The 61 genes in the RegulonDB target set were included as positive genes. We also 
included 39 E. coli genes which displayed the most variation across the 305 experiments  
and not in the RegulonDB target set as negative genes. We used the 100-gene test set to 




Spearman and Kendall correlation coefficients, mutual information and QDB. Using the 
default setting, BEST identified 28 target genes; 27 of them (96%) were in the 
RegulonDB target set (highly significant for enrichment with p-value of 1.27×10-6). 
BEST also identified 143 experimental conditions (47%) as foreground. The log-
likelihood trace plot suggested rapid convergence (Figure A2.4 in appendix). To compare 
the performance of our method with others, we plotted ROC curves (Figure 2.3). BEST 
achieved an AUC of 0.87, which was significantly higher than others (≤ 0.70). We also 





Figure 2.3 ROC curves for various query methods applying to the 100-gene test set 
selected from the E. coli microarray compendium. The area under the curves (AUC) are: 
Pearson correlation: 0.69; Spearman correlation: 0.69; Kendall’s : 0.66; QDB: 0.70; 









Figure 2.4 The original (blue line) and inverted (red line) expression profiles of gcvB, 
lysU, kbl and tdh compared to query gene Lrp. Black lines indicate the query gene—Lrp. 
Only the 143 foreground experimental conditions identified by BEST were shown in 









 Among the 28 genes BEST identified (Table A2.2 in appendix), only one gene, 
gcvB, was not in the RegulonDB target set. gcvB is a regulatory RNA. It represses oppA, 
dppA, gltI and livJ expression and is regulated by gcvA and gcvR (42). Until now there 
has been no evidence to suggest gcvB is regulated by Lrp. However, the trace plot 
(Figure 2.4) showed that its expression profile, after inversion, is very close to the 
expression profile of Lrp. Its expression profile is also very close to that of three genes 
found in the RegulonDB target set, lysU, kbl and tdh (Table 2.2 and Figure 2.4).  
Furthermore, the scan of Lrp motif pattern (Figure A2.5 in appendix) indicates that there 
is a putative Lrp motif located in the intergenic region upstream of gcvB. Therefore we 





Table 2.2 Information of the four genes showing inverse correlation patterns with Lrp identified by BEST when applied to the 100-
gene test set selected from the E. coli microarray compendium. All but the first one, gcvB, are in the RegulonDB target set.  
 
Rank Gene namea Log Bayes ratio Positive/Negativeb RegulonDBc CLRd Motif distancee Empirical p-valuef  
16 gcvB 107.80 Negative 
  
414 0.0047 
23 lysU 84.52 Negative X 
 
138 0.0044 
24 kbl 81.47 Negative X 
 
33 0.0019 
25 tdh 80.09 Negative X 
 
    
 
a Genes displayed here are sorted by the Log Bayes ratio (target gene versus non-target gene). 
b Blank indicates that the target gene shows the same pattern as the query gene. Negative indicates that the target gene shows the 
inversed pattern as the query gene. 
c ―X‖ indicates that the predicted gene is in the RegulonDB target set.  
d ―X‖ indicates that the gene is predicted by CLR as a target gene. 
e Motif distance is defined as the distance between the start position of the gene and the closest motif in the intergenic region upstream.  
f Empirical p-value indicates the significance of conservation in the current motif, which is calculated as proportion of all possible 
motif locations in the complete E. coli genome that have likelihood ratios comparing between Lrp motif and background higher than 




 Results from BEST also suggested that Lrp is likely to actively carry out most of 
its regulatory role under about half of all the 305 experimental conditions tested. To 
verify this hypothesis, we separately calculated Pearson correlation coefficients between 
the expression profiles of Lrp and genes in the RegulonDB target set in the 143 
foreground conditions as well as the 162 background conditions. We found that the 
Pearson correlation coefficient in the foreground subset was indeed significantly higher 
than that of the background subset. A paired t-test comparing the two sets of correlation 
coefficients returned a p-value of 0.0079. When restricted to the 28 genes BEST 
identified as targets, the difference in the matched correlation coefficients became even 
more significant (p-value of 1.948×10-12). Side-by-side box plots are shown in appendix 
Figure A2.6. The 305 experimental conditions were listed in Table A2.3 in appendix 
which was sorted by log Bayes ratio (larger values correspond to foreground). We found 
that many of the experimental conditions listed in the top portion are related to minimum 
media or stress which is consistent to what Faith et al. (2007) (13) found that including 
minimum media conditions will help identify Lrp targets.  
 The core of our model is the two-component Gaussian mixture for the expression 
levels obtained under the foreground experimental conditions. To verify this assumption, 
we plotted histograms of expression levels obtained under ten different experimental 
conditions, the top and bottom five when sorted by the Bayes ratio comparing whether an 
experimental condition is foreground or background. The histograms are shown in Figure 




experimental conditions show strong bi-modal shapes while those from the bottom five 
do not. 
2.3.2.2 Query result from 300-gene test set 
 To evaluate whether increased number of genes being queried and change in the 
proportion of negative genes affect BEST’s performance, we added an additional 200 
negative genes that showed high overall variations in all experiments to form a 300-gene 
test set. 
 Using the default setting in BEST, we identified 57 target genes (Table A2.4 in 
appendix) and 139 experimental conditions as foreground. Thirty-three of the target 
genes (58%) were in the RegulonDB target set (highly significant for enrichment with a 
p-value of 9.48×10-13). A recent microarray analysis suggested that Lrp may affect 
transcription of as much as 10% of all E. coli genes (43). Therefore it is highly likely that 
many genes that are not in the RegulonDB target set are indeed regulated by Lrp. Trace 
plots of the 24 hypothetical Lrp target genes are shown in Figure A2.8 in appendix.  
 We next compared our result to the 43 genes CLR predicted as Lrp targets in (13). 
The 239 negative genes we selected actually contain four genes that are on the 43 CLR 
predicted target gene list but not in the RegulonDB target set. Three of them, metE, ompT 
and yagU were also identified by BEST as Lrp target genes. In fact, they ranked first, 
second and sixth in the 24 hypothetical Lrp targets genes listed in Table A2.4 in 
appendix. Interestingly, two of them, ompT and yagU have been confirmed to be bound 
by Lrp in vivo using ChIP-qPCR (13). Furthermore, the scan of Lrp motif indicates that 




 We also plotted the histograms of expression levels obtained from the top and 
bottom five experimental conditions sorted by the Bayes ratio comparing whether an 
experimental condition is foreground or background (Figure A2.9 in appendix). We again 
observe strong bi-modal shapes in the histograms representing the top five experimental 
conditions but not in the histograms representing the bottom five.  
2.3.2.3 Query result from other TFs  
 In addition to Lrp, we also ran BEST on six other TFs (PdhR, FecI, LexA, FlhC, 
FlhD and FliA) to test its performance. Among them, LexA, a major regulator of DNA 
repair, is known to have a single well-conserved DNA binding motif. It is one of the best-
perturbed regulators in the microarray compendium due to the compendium’s emphasis 
on DNA-damaging conditions (13). Other TFs either regulate a large number of genes or 
have substantial connectivity in the network mapped by the CLR Algorithm (13). For 
each TF, we built a test set including all its target genes listed in regulonDB, together 
with genes predicted by CLR as target. We also included ~100 genes which displayed the 
most variation across the 305 experimental conditions as negative signals. The complete 
results are summarized in the appendix and all BEST predicted target genes are listed in 
Tables A2.5 – A2.10 in appendix. From these lists, we see that except for PdhR, the 
majority of target genes listed in regulonDB were identified by BEST. For example, all 
six FecI target genes, 29 out of 30 FlhC target genes and 41 out of 42 FliA target genes 
were identified. Furthermore, BEST identified all CLR predicted target genes at 60% 





 In summary, we developed a model-based query algorithm based on the Bayesian 
model selection framework. BEST, a computer program implements this algorithm, is 
able to query large and heterogeneous microarray gene expression databases for regulon 
discovery. The query operation considered here can be viewed as a classification 
procedure where genes sharing similar expression profiles with the query gene belong to 
one group and the rest belong to the other. Therefore, we considered BEST a supervised 
learning tool. The key feature of BEST is its ability to recognize co-expression under 
only a subset of experimental conditions.  
 In microarray experiments with only a few sample/experimental conditions, the 
GBA principle has been successfully applied to identify regulons of key TFs (44). When 
the experimental conditions are abundant and heterogeneous such as in the case of 
microarray compendium, the previous strategy will not be as successful since most TFs 
are only active under certain specific conditions and beyond those conditions no tight 
correlation is expected between TF and its regulons. BEST is built under the hypothesis 
that the correlation between TF and its regulon only hold in a subset of conditions. The 
objective of BEST is to simultaneously predict regulon of a TF and the experimental 
conditions associated with them. Tests conducted on simulated as well as real datasets 
indicated that the new algorithm works well and outperforms methods based on global 
correlation measures, especially when there is substantial noise and moderate distortion 
in the data.  
 We are encouraged that when applying BEST to the real E. coli compendium 




the TF. Interestingly, numerous genes identified show inversed correlation pattern with 
Lrp. Table 2.2 lists four such genes, three of them are known to be regulated by Lrp, and 
the other one showed a very similar pattern with the three known ones. None of these 
four genes is predicted by CLR. We also believe that many of the ―false positive‖ genes 
are likely to be real Lrp target genes as well since as many as 10% of all E. coli genes are 
believed to be regulated by Lrp (43) which is significantly larger than the size of the 
current RegulonDB target set. We also tested major TFs whose target set is larger than 
ten. Querying these TFs showed that BEST is able to identify the majority of their known 
target genes. These results suggested that the hypothesis BEST assumed is reasonable. 
Using microarray compendium data, we are able to generate high confidence and testable 
hypothesis on TF-regulon relationships.  
 On the other hand, there are numerous genes in the RegulonDB target sets that 
were not identified by BEST. Visual inspection of these gene expression trace plots 
confirms that their expression profiles do not resemble the TF that is supposed to regulate 
them. This observation suggests that there are limitations on using the GBA principle on 
gene expression information alone to identify regulons of a TF. There are various reasons 
why GBA is insufficient to identify the full set of regulon. It is possible that the 
compendium does not include the experimental conditions under which these genes were 
regulated by the TF. It is possible that microarray gene expression data is not accurate 
enough due to measurement error and its limitation in quantifying low-level expression. 
It is also possible that due to the complexity in regulatory mechanism, some TF-regulon 
relationships do not imply co-expression under any condition.  For example, the TF may 




Other complex regulatory mechanisms such as post-translational modification, chromatin 
modification, and microRNA regulation may also explain what we observed.   
 In this study, we assumed that all columns are independent and there is no 
covariance.  This is because replicates in our data have already been merged and adding 
covariance will significantly increase the complexity of our model. Admittedly, when 
there are biological or technical replicates, adding covariance in our model will improve 
the result. We plan to add this option in future releases of BEST.  
 It is possible to perform a genome-wide search using BEST for genes co-
expressed with the query gene. To reduce computation time and to maximize the chance 
of finding biologically meaningful targets, we recommend a filtering step to reduce the 
search space. In this study, we adopted a variance filter, which is typical in large-scale 
gene expression clustering analysis (45) to remove genes that show less variation than the 
query gene when considering all experimental conditions. We tested this strategy on Lrp 
in E. coli. There are 524 genes (out of 4217 in total, 12%) with total expression variance 
greater than that of Lrp. They contain 30 genes (out of 61, 49%) that are in the 
RegulonDB target set. Running BEST with the default setting on this dataset identified 
77 genes as targets. Among them, 18 are among the 30 known Lrp target genes 
(enrichment p-value is 3.32×10-9). Compared to the CLR prediction in (13), seven of the 
43 CLR predicted target genes that are not in the RegulonDB targets set are among the 
524 genes tested. Six of them, gdhA, metE, ompT, pntA, thrA, yagU were also identified 
by BEST. All but metE have been confirmed in vivo as Lrp targets using ChIP-qPCR 
(13). The 139 experimental conditions identified by BEST as foreground are essentially 




feasibility of our genome-wide search strategy. One can lower the variance threshold to 
expand the search space if longer computing time can be tolerated.  
 The statistical model adopted in BEST is closely related to those used in various 
model-based clustering methods designed for analyzing microarray data (46-51). 
However, as a supervised learning tool, BEST is able to automatically distinguish the two 
sets of genes using the expression profile of the pre-specified query gene. This is 
particularly valuable for searching specific expression patterns of interest. The user can 
even specify a custom expression pattern to search. In addition, our method allows 
linearly transformed expression patterns to be recognized and is robust against sporadic 
outliers in the data. 
 Our algorithm is built under the Bayesian model selection framework, which may 
easily incorporate prior biological information. For example, some genes or experimental 
conditions can be designated as targets or foreground. Similarly, informative priors on 
cell indicators can help to rule out some sporadic outliers.  
 MCMC-based methods are typically computation- intensive and therefore time-
consuming. BEST’s running time depends on the number of iterations and on the size of 
the dataset. In the study on E. coli microarray compendium dataset, using the default 
setting which is ten parallel chains each with 50 cycles, searching 100 genes takes about 
30 minutes on a PowerMac with dual 2.5 GHz processors. Searching 300 and 524 genes 
takes about 3 hours and 30 hours respectively. A computer program named BEST has 






2.5.1 Prior specification 
 We adopt standard conjugate priors for the model parameters. The prior 
parameters , , ,  and  are specified as follows: 
 First we estimate the linear transformation factor  using least square without 
intercept. To keep our model simple and avoid over-fitting, the linear transformation 
factor  is restricted to be significantly different from 0. The difference  is defined as 
. 
 We calculate the sample mean  and sample variance  of the difference  
in each column, and set . Next we calculate the sample variance  of column 
variance , and choose , , such that the prior distribution 
has mean  and variance . 
 To choose ,  in each column, we select  with absolute value less than 
 in that column and calculate their sample variance . Let  be the variance of 
all s, and choose  and , such that the prior distribution 
 has mean  and variance . 
 We use non- informative priors for row indicator , column indicator  and cell-
level indicator , i.e., . 
2.5.2 Full conditional distribution 











The marginal posterior distribution is: 
 
 


















The marginal posterior distribution is: 
 
 









2.5.3 Detail protocol of microarray data analysis procedure using BEST 
 The E. coli dataset originally came from the study reported in Faith et al. (2007) 
(13). The authors conducted a comprehensive survey of gene expression profiles of all E. 
coli genes using 612 Affymetrix GeneChip arrays treated with 305 different experimental 
conditions. RMA normalized data (Faith et al., 2008) (39) was used in this study, which 
consisted of 4,217 genes and 305 samples. The detail of microarray data analysis 
procedure, such as microarray profiling, bacterial strains, steady-state experiments, time-
course experiments, preparation of RNA and hybridization, external data, microarray 
normalization, are available at (Faith et al., 2007) (13). 
 Step 1: download microarray compendium data file 
―E_coli_v4_Builid_4_norm.tar.gz‖ from http://m3d.bu.edu/norm/?C=M;O=A. This 
zipped data file describes the normalized compendium dumps from M3D, which contains 
six files with expression data. ―avg_E_coli_v4_Build_4_exps305probes4217.tab‖, the 
expression data file which contains 305 experimental conditions and 4,217 genes, was 
used in our study. 
 Step 2: get the expression profile of the query gene, for example: Lrp, from the 
microarray compendium ―avg_E_coli_v4_Build_4_exps305probes4217.tab‖, which is 




 Step 3: filter genes based on their variances. First, we calculated the variances of 
all 4,217 genes found in the microarray compendium. We then remove all genes whose 
variation across all experimental conditions is less than the query gene. This purpose of 
filtering is to reduce computation time and to maximize the chance of finding biological 
meaningful targets. For the query gene Lrp, there are 524 genes (out of 4,217 in total, 
12%) with total expression variance greater than that of Lrp. We thus used these 524 
candidate genes in our search. 
 Step 4: normalize the query gene and the 524 candidate genes. First, we 
calculated the mean and standard deviation across the 305 experimental conditions for 
each gene, and then normalize each of the gene expression levels by subtracting its mean 
and dividing by its standard deviation. After normalization, the query gene Lrp and the 
524 candidate genes all have the same mean and variance (mean=0 and standard 
deviation=1). 
 Step 5: run BEST on the normalized gene expression levels using user-specified 
parameters such as the number of iteration in MCMC and the number of parallel cha ins.  
 Step 6: conduct motif search. We download position specific weight matrices 
(PSWM) from RegulonDB 
 (http://regulondb.ccg.unam.mx/data/Matrix_AlignmentSet.txt), and the complete E. coli 
genome from GenBank  
(ftp://ftp.ncbi.nih.gov/genbank/genomes/Bacteria/Escherichia_coli_K12_substr__MG165
5/U00096.fna). We then calculated the log likelihood ratio comparing between the motif 




(up to 500 bp upstream) of genes identified by BEST. The locations with log likelihood 
ratio higher than a certain threshold are treated as putative motifs.  
2.5.4 Query result from six other transcription factors  
 In addition to TF Leucine-responsive Regulatory Protein (Lrp), we used another 
six TFs (PdhR, FecI, LexA, FlhC, FlhD and FliA) as the query genes in this study to test 
BEST’s performance. All six TFs have an almost equal number of target genes in 
ReglonDB and CLR prediction with an estimated 60% precision (Faith et al. 2007) (13).  
2.5.4.1 Query result from PdhR 
 PdhR has five target genes in ReglonDB. CLR predicted four target genes with 
60% precision. None of them is in the RegulonDB target set. We included these nine 
genes and another 91 negative genes to form a 100 gene test set. BEST found 27 target 
genes and 179 experimental conditions as foreground. Twenty-seven of BEST’s target 
genes included two target genes in ReglonDB and four target genes predicted by CLR (p-
value of 0.0110). We found three genes (uspE, cspD, aceA) with inversed pattern. Table 
A2.5 lists all PdhR target genes identified by BEST. 
2.5.4.2 Query result from FecI 
 FecI has six target genes in ReglonDB. CLR predicted eight target genes with 
60% precision. Eight of these nine predictions are not in the RegulonDB target set. We 
included these 13 genes and another 87 negative genes to form a 100 gene test set. BEST 
found 31 target genes and 169 experimental conditions as foreground. Thirty-one of 
BEST’s target genes included all 13 target genes in ReglonDB and target genes predicted 
by CLR (p-value of 2.9×10-8). We found no gene with inversed pattern. Table A2.6 lists 




2.5.4.3 Query result from LexA 
 LexA has 16 target genes. CLR predicted 17 targets genes with 60% precision. 10 
of these 17 predictions are not in the RegulonDB target set. We included these 26 genes 
and another 74 negative genes to form a 100 gene test set. BEST found 31 target genes 
and 237 experimental conditions as foreground. Thirty-one of BEST’s target genes 
included 10 target genes in ReglonDB and all target genes predicted by CLR (p-value of 
1.5×10-8). We found one gene (uspE) with inversed pattern. Table A2.7 lists all LexA 
target genes identified by BEST. 
2.5.4.4 Query result from FlhC 
 FlhC has 30 target genes in ReglonDB. CLR predicted 53 targets genes with 60% 
precision. 24 of these 53 predictions are not in the RegulonDB target set. We included 
these 54 genes and another 146 negative genes to form a 200 gene test set. BEST found 
54 target genes and 266 experimental conditions as foreground. Fifty-four of BEST’s 
target genes included 29 target genes in ReglonDB and all target predicted by CLR (p-
value of 2.7×10-46). We found no gene with inversed pattern. yjdA is the new 
hypothetical FlhC target gene identified by BEST in addition to false pos itive genes in 
Faith’s prediction with 60% precision. Table A2.8 lists all FlhC target genes identified by 
BEST. 
2.5.4.5 Query result from FlhD 
 FlhD has 46 target genes in ReglonDB. CLR predicted 46 target genes with 60% 
precision. Twenty of these 46 predictions are not in the RegulonDB target set. We 
included these 66 genes and another 134 negative genes to form a 200 gene test set. 




BEST’s target genes included 29 target genes in ReglonDB and all target genes predicted 
by CLR (p-value of 1.67×10-17). We found two genes (micF, gadX) with inversed pattern. 
cheY, cheZ, flxA, micF, gadX and yjdA are the six new hypothetical FlhD target genes 
identified by BEST in addition to false positive genes predicted by CLR with 60% 
precision. Table A2.9 lists all FlhC target genes identified by BEST.  
2.5.4.6 Query result from FliA 
 FliA has 42 target genes in ReglonDB. CLR predicted 56 target genes with 60% 
precision. Fifteen of these 56 predictions are not in the RegulonDB target set. We 
included these 57 genes and another 143 negative genes to form a 200 gene test set. 
BEST found 56 target genes and 281 experimental conditions as foreground. Fifty-six of 
BEST’s target genes included 41 genes in ReglonDB and all target predicted by CLR (p-
value of 4.08×10-47). We found no genes with inversed pattern, and no new hypothetical 
FliA target gene identified by BEST in addition to false positive genes predicted by CLR 





2.5.5 Tables in appendix 
Table A2.1. Performance comparison using area under the curve (AUC) of Receiver Operating Characteristic (ROC) among various 
methods for querying simulated microarray gene expression datasets. Best results are displayed in bold.  
 
Case Sub-case* Pearsona Spearmanb Kendallc QDBd Mutuale  BEST Af BEST Bg BEST Ch 
Case 1: I 1 1 1 1 1 1 1 1 
100% II 0.68 0.68 0.68 0.85 1 1 1 1 
foreground III 1 1 1 1 1 1 1 1 
  IV 0.66 0.71 0.71 0.79 0.85 1 1 1 
Case 2: I 0.98 1 1 1 0.98 1 1 1 
75% II 0.7 0.71 0.71 0.89 0.95 1 1 1 
foreground III 0.99 1 1 1 0.98 1 1 1 
  IV 0.67 0.71 0.71 0.84 0.88 1 1 1 
Case 3: I 0.89 0.93 0.95 0.99 0.87 1 1 1 
50% II 0.67 0.69 0.69 0.89 0.81 1 1 1 
foreground III 0.88 0.92 0.94 0.92 0.84 1 1 1 
  IV 0.59 0.62 0.64 0.77 0.69 0.98 0.99 0.99 
Case 4: I 0.68 0.69 0.71 0.55 0.61 0.91 0.98 0.99 
25% II 0.55 0.55 0.56 0.51 0.58 0.85 0.92 0.99 
foreground III 0.67 0.68 0.69 0.51 0.59 0.93 0.98 0.99 







* There are four sub-cases in each of the simulated cases with the same amount of foreground columns.  
Sub case I: no linear transformation; 
Sub case II: only add linear transformation; 
Sub case III: only add cell- level noise; 
Sub case IV: add both linear transformation and cell- level noise. 
a Query method using Pearson correlation coefficient.  
b Query method using Spearman correlation coefficient.  
c Query method using Kendall’s . 
d Query method using QDB. 
e Query method using mutual information. 
f Query method using BEST. 
gQuery method using BEST allowing exclusion of individual cells from the foreground. 




Table A2.2 Information of the 28 potential Lrp target genes identified by BEST when 
applied to the 100-gene test set selected from the E. coli microarray compendium. 
 
Rank Gene Namea Log Bayes Ratio positive/negativeb RegulonDBc CLRd 
1 serA 131.81 
 
X X 
2 leuA 129.99 
 
X X 
3 leuL 128.72 
 
X X 
4 gltD 128.22 
 
X X 
5 leuD 123.19 
 
X X 
6 ilvI 120.44 
 
X 
 7 ilvH 119.61 
 
X X 
8 gltB 119.04 
 
X 
 9 leuC 116.22 
 
X X 
10 livG 115.37 
 
X X 
11 ilvE 114.30 
 
X 
 12 livK 113.30 
 
X X 
13 leuB 110.28 
 
X X 
14 livJ 109.72 
 
X 
 15 livM 108.48 
 
X 
 16 gcvB 107.80 negative 
  17 serC 103.20 
 
X X 
18 aroA 97.58 
 
X X 
19 livH 94.76 
 
X X 
20 livF 93.82 
 
X X 
21 ilvL 90.43 
 
X 
 22 ilvD 89.88 
 
X 
 23 lysU 84.52 negative X 
 24 kbl 81.47 negative X 
 25 tdh 80.09 negative X 
 26 ilvG 79.47 
 
X 
 27 ilvM 71.23 
 
X X 
28 ilvA 65.02 
 
X   
 
a Genes displayed here are sorted by Log Bayes ratio (target gene versus non-target gene). 
b Blank indicates that the target gene shows the same pattern as the query gene. Negative 
indicates that the target gene shows the inversed pattern as the query gene.  
c BEST indentifies 27 genes among 61 target genes in RegulonDB.  ―X‖ indicates that the 
predicted gene is in the RegulonDB target set.  




Table A2.3 Information on the 305 distinct experimental conditions (among 612 different 
chips with replicates). The 305 experimental conditions are sorted by log Bayes ratio. 
BEST predicts the top 143 as foreground and the rest as background. Detail information 
of these 612 chips and 305 experimental conditions could be found in microarray 
compendium data file ―E_coli_v4_Builid_4_norm.tar.gz‖ from the Gardner Lab. 
(http://m3d.bu.edu/norm/?C=M;O=A)  
 
Rank Experimental Conditions Replicates Log Bayes Ratio 
1 M9_K_arcA_anaerobic 3 50.47  
2 M9_WT 3 48.79  
3 M9_K_appY_anaerobic 3 44.81  
4 M9_K_soxS_anaerobic 3 43.21  
5 M9_K_arcA 3 38.07  
6 M9_K_oxyR_anaerobic 3 37.60  
7 M9_K_soxS 3 37.23  
8 M9_K_arcAfnr 3 37.02  
9 M9_WT_anaerobic 4 35.75  
10 M9_K_oxyR 3 35.52  
11 lacZ_W1863_t0 1 35.24  
12 M9_K_fnr 3 34.34  
13 ccdB_MG1655_t30 2 34.14  
14 M9_K_fnr_anaerobic 3 34.05  
15 ccdB_W1872_t60 1 31.42  
16 lacZ_W1863_t60 1 31.11  
17 ccdB_W1872_t30 1 30.66  
18 ccdB_W1872_t90 1 29.37  
19 M9_K_appY 3 29.01  
20 lacZ_MG1063_t0 2 27.61  
21 ccdB_MG1655_t0 2 26.92  
22 norfloxacin_chelator_MG1063_t0 1 26.75  
23 ccdB_chelator_MG1063_t0 1 26.31  
24 ccdB_chelator_MG1063_t60 1 26.12  
25 lacZ_W1863_t30 1 25.47  
26 fnr_K_fnrAnaerobic 4 25.21  
27 cybr_N_log 2 24.95  
28 MG1063_uninduced_t0 1 24.50  
29 MG1063_uninduced_t60 1 24.36  
30 MG1063_uninduced_t30 1 24.22  




32 MG1655_ampicillin_t120 1 23.40  
33 ccdB_chelator_W1872_t0 1 23.30  
34 MG1655_ampicillin_t30 1 23.23  
35 ik_H2_T3 1 23.04  
36 fnr_wtAnaerobic 3 22.85  
37 ik_L2_T3.5 1 22.80  
38 norfloxacin_BW25113_t120 1 22.59  
39 norfloxacin_BW25113recA_t60 1 22.39  
40 har_S1_R_noIPTG 3 21.62  
41 ccdB_chelator_MG1063_t30 1 21.60  
42 cybr_O_log 2 21.56  
43 biofilm_4hr 1 21.32  
44 ph5.7_anaerobic 5 21.24  
45 carbonSourceForaging 2 21.02  
46 WT_MOPS_glucose 5 20.77  
47 ik_L2_T4 1 20.38  
48 M9_K_arcAfnr_anaerobic 3 20.28  
49 WT_MOPS_glycerol 2 20.08  
50 ik_H2_T3.5 1 19.86  
51 MG1655_uninduced_t0 1 19.36  
52 luc2_U_N0000 2 19.30  
53 MG1655_ampicillin_t60 1 18.85  
54 ccdB_BW25113recA_t120 1 18.84  
55 ik_L2_T3 1 18.77  
56 menC_U_N0075 3 18.76  
57 crcB_U_N0075 3 18.69  
58 MG1655_t480_aerobic 2 18.61  
59 cpxR_U_N0075 3 18.31  
60 era_U_N0075 3 18.26  
61 crp_U_N0075 3 18.09  
62 luc_U_N0075 3 18.00  
63 gcvR_U_N0075 3 17.83  
64 dnaA_U_N0075 3 17.79  
65 menB_U_N0075 3 17.65  
66 fis_U_N0075 3 17.62  
67 ccdB_BW25113recA_t30 1 17.60  
68 ccdB_MG1063_t0 2 17.18  
69 ik_H2_T2.5 1 17.04  
70 WT_N0075 2 17.04  
71 ccdB_W1872_t0 1 16.89  




73 norfloxacin_BW25113recA_t30 1 16.59  
74 MG1655_t270_anaerobic 2 16.35  
75 lacZ_W1863_t90 1 16.27  
76 rimI_U_N0075 3 16.19  
77 minD_U_N0075 3 16.15  
78 zipA_U_N0075 3 15.99  
79 dinP_U_N0025 3 15.75  
80 lacZ_MG1063_t30 2 15.74  
81 mcrB_U_N0075 3 15.62  
82 ccdB_BW25113recA_t180 1 15.53  
83 MG1655_uninduced_t60 1 15.48  
84 norfloxacin_chelator_MG1063_t0.1 1 15.34  
85 yebF_U_N0075 3 15.21  
86 MG1655_t150_aerobic 2 15.13  
87 ccdB_BW25113_t180 1 15.01  
88 biofilm_wt_noGlucose 1 14.83  
89 MG1655_t225_anaerobic 2 14.75  
90 ccdB_BW25113_t30 1 14.61  
91 ast_pBADsup2 3 14.50  
92 ph7 5 14.17  
93 recA_U_N0025 3 13.88  
94 MG1655_t300_aerobic 2 13.71  
95 uspA_U_N0075 3 13.53  
96 norfloxacin_MG1063_t0 1 13.47  
97 mcrC_U_N0075 3 13.41  
98 bcp_U_N0075 3 13.22  
99 b2618_U_N0075 3 13.19  
100 pepAA_t0 2 13.00  
101 nupC_U_N0075 3 12.84  
102 ldrA_U_N0075 3 12.34  
103 ccdB_K12_t90 1 12.15  
104 lacZ_K12_t60 1 12.09  
105 BW25113_uninduced_t120 1 11.80  
106 yoeB_U_N0075 3 11.71  
107 minE_U_N0075 3 11.48  
108 ph7_anaerobic 5 11.45  
109 luc_U_N0025 3 11.44  
110 ast_pBAD18 3 11.42  
111 MG1655_t405_aerobic 2 11.28  
112 sbcB_U_N0075 3 10.53  




114 lacZ_MG1655_t0 1 10.36  
115 MG1655_t1080_aerobic 2 9.96  
116 gyrA_U_N0075 3 9.66  
117 har_S0_R_noIPTG 5 9.52  
118 norfloxacin_BW25113_t180 1 9.51  
119 suspension_4hr 1 9.45  
120 W3110_K_luxS 2 9.23  
121 murI_U_N0075 3 8.80  
122 MG1655_uninduced_t120 1 8.43  
123 BW25113recA_uninduced_t180 1 7.97  
124 folA_U_N0075 3 7.76  
125 lacZ_K12_t30 1 7.69  
126 cspF_U_N0075 3 7.61  
127 dnaN_U_N0075 3 6.63  
128 ccdB_BW25113recA_t0 1 6.57  
129 W3110_wt 2 6.43  
130 ccdB_K12_t30 1 5.91  
131 hlpA_U_N0075 3 5.48  
132 MG1655_uninduced_t30 1 4.20  
133 biofilm_7hr 1 3.80  
134 T60_N10000 3 3.16  
135 MG1655_t180_anaerobic 2 2.78  
136 WT_N0000 2 2.69  
137 dinI_U_N0025 3 0.68  
138 BW25113recA_uninduced_t120 1 0.29  
139 ccdB_BW25113recA_t60 1 0.29  
140 ik_L2_T4.5 1 0.22  
141 dam_U_N0075 3 0.05  
142 lacZ_MG1655_t60 1 -0.22  
143 rstB_U_N0075 3 -0.71  
144 pepAA_t30 2 -1.03  
145 dnaT_U_N0075 3 -1.16  
146 MGD1_t30 2 -1.26  
147 norfloxacin_BW25113recA_t0 1 -1.62  
148 gyrI_U_N0075 3 -1.83  
149 MG1655_kanamycin_t120 1 -1.95  
150 ik_H2_T8 1 -2.05  
151 sulA_U_N0025 3 -2.29  
152 umuD_U_N0025 3 -2.38  
153 ccdB_K12_t60 1 -2.44  




155 ik_H2_T4.5 1 -2.56  
156 norfloxacin_BW25113_t30 1 -2.93  
157 lacZ_MG1655_t90 1 -2.93  
158 ik_H2_T6 1 -3.02  
159 ik_L2_T2.5 1 -3.04  
160 ruvA_U_N0025 3 -3.06  
161 ccdB_BW25113_t0 1 -3.09  
162 lexA_U_N0025 3 -3.54  
163 ik_L2_T5.5 1 -3.60  
164 holD_U_N0075 3 -3.87  
165 nrdA_U_N0075 3 -4.06  
166 ccdB_K12_t120 1 -4.15  
167 WT_D_N0100 2 -4.29  
168 pepCO_t30 2 -4.37  
169 lon_U_N0025 3 -4.56  
170 recA_D_N0100 2 -4.60  
171 MG1655_kanamycin_t60 1 -4.62  
172 MG1655_kanamycin_t30 1 -4.65  
173 ccdB_BW25113_t60 1 -4.90  
174 galF_U_N0075 3 -5.04  
175 ruvC_U_N0075 3 -5.24  
176 T48_N10000 3 -5.43  
177 MG1063_uninduced_t120 1 -5.44  
178 ccdB_chelator_W1872_t30 1 -5.66  
179 lacZ_MG1063_t90 2 -5.84  
180 BW25113recA_uninduced_t0 1 -5.95  
181 uvrA_U_N0025 3 -6.13  
182 IHF_U_N0075 2 -6.15  
183 MOPS_K_dps_stationary2 1 -6.15  
184 relA_U_N0025 3 -6.27  
185 BW25113recA_uninduced_t30 1 -7.01  
186 emrR_U_N0075 2 -7.21  
187 ik_H2_T4 1 -7.22  
188 cybr_O 2 -7.24  
189 WT_MOPS_stationary3 2 -7.39  
190 WT_MOPS_heatShock 1 -7.60  
191 MOPS_K_dps_stationary 2 -7.61  
192 cybr_N 2 -7.66  
193 luc_U_N0000 3 -7.72  
194 ph8.5_anaerobic 5 -7.86  




196 ph5 5 -8.10  
197 BW25113_uninduced_t30 1 -8.33  
198 cybr_N_stat 2 -8.51  
199 WT_MOPS_stationary2 2 -8.53  
200 hscA_U_N0075 3 -8.60  
201 ik_L2_T6 1 -8.67  
202 ik_H2_T5.5 1 -8.94  
203 mazF_U_N0025 3 -9.11  
204 pET3d_t0 2 -9.19  
205 luc2_U_N0025 2 -9.21  
206 T24_N10000 3 -9.22  
207 nrdB_U_N0075 2 -9.36  
208 BW25113_uninduced_t180 1 -9.42  
209 T36_N10000 3 -9.74  
210 MG1655_spectinomycin_t30 1 -9.74  
211 norfloxacin_BW25113_t60 1 -9.75  
212 WT_MOPS_cipro2 1 -10.61  
213 ccdB_MG1655_t60 2 -10.66  
214 MGD1_t0 2 -10.98  
215 WT_MOPS_acetate 2 -10.99  
216 ccdB_chelator_MG1063_t120 1 -11.15  
217 ccdB_MG1063_t30 2 -11.39  
218 lacZ_K12_t120 1 -11.41  
219 cybr_O_stat 2 -11.44  
220 W3110_K_luxS_glucose 1 -11.44  
221 lacZ_MG1063_t60 2 -11.71  
222 ccdB_BW25113_t120 1 -11.87  
223 ccdB_MG1655_t90 2 -11.91  
224 ik_L2_T5 1 -12.14  
225 WT_MOPS_proline 2 -12.22  
226 recA_D_N0050 2 -12.34  
227 WT_MOPS_stationary4 2 -12.42  
228 WT_MOPS_cipro 1 -12.81  
229 WT_N0025 2 -12.92  
230 T12_N10000 3 -13.07  
231 lacZ_MG1063_120 1 -13.07  
232 BW25113recA_uninduced_t60 1 -13.11  
233 fnr_K_fnrAerobic 3 -13.21  
234 MG1655_t150_anaerobic 2 -13.42  
235 norfloxacin_BW25113_t0 1 -13.55  




237 WT_MOPS_acidShock 2 -13.77  
238 MG1655_spectinomycin_t60 1 -13.82  
239 MG1655_spectinomycin_t120 1 -14.22  
240 biofilm_15hr 1 -14.39  
241 K12_t360 3 -14.44  
242 ccdB_K12_t0 1 -14.44  
243 WT_MOPS_lateLog 3 -14.46  
244 suspension_15hr 1 -15.01  
245 W3110_wt_glucose 2 -15.23  
246 har_S4_noIPTG 3 -15.91  
247 norfloxacin_BW25113recA_t120 1 -16.73  
248 ik_H2_T5 1 -16.96  
249 har_S1_noIPTG 3 -16.97  
250 norfloxacin_MG1063_t30 1 -17.00  
251 lacZ_MG1655_t30 1 -17.38  
252 pepCO_t0 2 -17.62  
253 lacZ_K12_t0 1 -17.85  
254 lacZ_K12_t90 1 -18.07  
255 har_S1_IPTG 3 -18.16  
256 MOPS_K_cspA 1 -18.20  
257 MG1655_t86400_cecum 5 -18.47  
258 BW25113_uninduced_t60 1 -18.67  
259 norfloxacin_chelator_MG1063_t0.2 1 -18.95  
260 norfloxacin_chelator_MG1063_t0.3 1 -19.00  
261 MG1655_t1560_aerobic 2 -19.27  
262 biofilm_24hr 1 -19.31  
263 biofilm_K_yceP 1 -19.35  
264 MG1655_norfloxacin_t30 1 -19.60  
265 MG1655_norfloxacin_t120 1 -19.95  
266 har_S0_noIPTG 3 -20.33  
267 MOPS_K_dps 3 -20.40  
268 cybr_KNO_N 2 -20.71  
269 har_S4_IPTG 3 -21.49  
270 ph8.7 5 -21.97  
271 K12_t150_K_fis 3 -22.24  
272 ik_L2_T8 1 -22.32  
273 T24_N0000 3 -22.43  
274 pET3d_t30 2 -22.91  
275 K12_t90_K_fis 3 -23.30  
276 BW25113_uninduced_t0 1 -23.45  




278 biofilm_K_yceP_indole 2 -25.13  
279 WT_N0050 2 -25.65  
280 T60_N0000 3 -25.75  
281 MOPS_K_hupB 1 -26.19  
282 norfloxacin_MG1063_t60 1 -26.30  
283 WT_MOPS_stationary 2 -26.59  
284 K12_t240_K_fis 3 -26.70  
285 K12_t150 3 -27.19  
286 har_S4_R_IPTG 3 -27.85  
287 norfloxacin_BW25113recA_t180 1 -29.03  
288 ccdB_MG1063_t60 2 -29.70  
289 MG1655_norfloxacin_t60 1 -30.08  
290 ccdB_MG1063_t120 1 -31.01  
291 ccdB_chelator_W1872_t60 1 -31.04  
292 K12_t240 3 -32.33  
293 MOPS_K_crp 3 -32.52  
294 MG1063_uninduced_t180 1 -32.69  
295 biofilm_K_tnaA 1 -32.85  
296 MOPS_K_hns 3 -33.23  
297 ccdB_chelator_W1872_t120 1 -33.23  
298 suspension_24hr 1 -33.70  
299 biofilm_wt_glucose 1 -34.55  
300 har_S1_R_IPTG 3 -35.58  
301 biofilm_K_trpE 1 -37.15  
302 ccdB_MG1063_t90 2 -37.89  
303 norfloxacin_MG1063_t120 1 -45.15  
304 K12_t90 3 -45.89  














Table A2.4 Information on the 57 potential Lrp target genes identified by BEST in the 
300-gene test set extracted from the E. coli compendium.  
 
Rank Gene Namea Log Bayes Ratio positive/negativeb RegulonDBc CLRd 
1 serA 187.80 
 
X X 
2 gltD 182.97 
 
X X 
3 metE 180.95 
  
X 
4 leuL 178.03 
 
X X 
5 leuD 175.01 
 
X X 
6 leuA 174.43 
 
X X 
7 gltB 173.30 
 
X 
 8 livG 172.80 
 
X X 
9 livJ 172.44 
 
X 
 10 ilvE 172.35 
 
X 
 11 ompT † 169.81 
  
X 
12 pyrI 169.77 
   13 livK 169.16 
 
X X 
14 ilvH 168.41 
 
X X 
15 leuC 168.10 
 
X X 
16 ilvI 168.00 
 
X 
 17 gcvB 166.47 negative 
  18 serC 164.09 
 
X X 
19 livM 163.56 
 
X 
 20 leuB 163.18 
 
X X 
21 pyrB 161.91 
   22 yagU † 158.71 
  
X 
23 aroA 158.46 
 
X X 
24 cysD 158.39 
   25 ilvD 157.84 
 
X 
 26 lysU 157.56 negative X 
 27 livH 157.28 
 
X X 
28 livF 155.74 
 
X X 
29 stpA 153.87 
 
X 
 30 cysK 152.23 
   31 pheL 151.32 
   32 tnaC 149.80 negative 
  33 dppA 148.70 
   34 cysN 147.61 





36 treC 143.28 negative 
  37 ilvL 142.44 
 
X 
 38 tdh 140.63 negative X 
 39 pyrL 140.4 
   40 ilvC 139.63 
   41 sdaA 138.77 negative X 
 42 sdaC 136.96 negative 
  43 ilvA 136.74 
 
X 
 44 thrL 135.9 
   45 hisL 135.55 
   46 yeeD 133.82 
   47 ilvM 131.85 
 
X X 
48 treB 130.2 negative 
  49 ompF 129.21 
 
X 
 50 fdoG 127.87 negative 
  51 oppA 127.26 
 
X 
 52 oppB 124.59 
 
X 
 53 rmf 122.65 
   54 oppF 122.24 
 
X 
 55 ynaJ 118.39 
   56 ilvG 113.06 
 
X 
 57 sroF 109.54       
 
a Genes displayed here are sorted by the Log Bayes ratio (target gene versus non-target 
gene). 
b Blank mean the target gene shows the same pattern as the query gene. Negative means 
the target gene shows the inversed pattern as the query gene.  
c BEST indentifies 33 genes among 61 target genes in RegulonDB. ―X‖ indicates that the 
predicted gene is in the RegulonDB target set. 
d ―X‖ indicates that the gene is predicted by CLR as a target gene.  











Table A2.5 Information on the 27 potential PdhR target genes identified by BEST in the 
100-gene test set extracted from the E. coli compendium.  
 
Rank Gene Namea Log Bayes Ratio positive/negativeb RegulonDBc CLRd 
1 recN 348.48 
   2 intE 342.08 
   3 recA 337.20 
   4 tisB 336.43 
   5 xisE 332.99 
   6 araB 330.06 
   7 araA 328.56 
   8 sulA 328.12 
   9 araD 327.70 
   10 ymfJ 322.03 
   11 ymfT 317.29 
   12 ymfL 316.94 
   13 araE 314.20 
   14 murC 307.50 
  
X 
15 ftsW 306.20 
  
X 
16 murD 304.53 
  
X 
17 ndh 298.38 
  
X 
18 aceE 283.28 
 
X 
 19 aceF 279.67 
 
X 
 20 uspE 275.72 negative 
  21 proV 274.19 
   22 cspD 267.67 negative 
  23 isrB 263.68 
   24 spf 248.58 
   25 cspA 239.93 
   26 tisA 221.34 
   27 aceA 76.68 negative     
 
a Genes displayed here are sorted by Log Bayes ratio (target gene versus non-target gene). 
b Blank indicates that the target gene shows the same pattern as the query gene. Negative 
indicates that the target gene shows the inversed pattern as the query gene.  
c BEST indentifies two genes among five target genes in RegulonDB. ―X‖ indicates that 
the predicted gene is in the RegulonDB target set.  




Table A2.6 Information on the 31 potential FecI target genes identified by BEST in the 
100-gene test set extracted from the E. coli compendium.  
 
Rank Gene Namea  Log Bayes Ratio positive/negativeb RegulonDBc CLRd 
1 ymfT 206.62 
   2 ymfJ 200.23 
   3 ymfL 196.67 
   4 araD 189.08 
   5 xisE 185.50 
   6 araB 185.40 
   7 araA 182.57 
   8 recN 177.90 
   9 araE 177.45 
   10 tisB 146.18 
   11 tisA 144.54 
   12 sulA 133.96 
   13 recA 118.89 
   14 proV 81.52 
   15 fecE 72.40 
 
X 
 16 fecB 67.88 
 
X 
 17 isrB 63.99 
   18 fecD 63.63 
 
X 
 19 fecC 63.13 
 
X 
 20 fecA 62.00 
 
X 
 21 fhuF 54.12 
  
X 
22 ybaN 53.60 
  
X 
23 exbB 46.24 
  
X 
24 fhuA 44.64 
  
X 
25 exbD 43.74 
  
X 
26 fecR 43.29 
 
X X 
27 bfd 33.30 
   28 micF 32.89 
   29 spf 29.53 
   30 cspA 19.14 
   31 entB -0.34 
 
  X 
 





b Blank indicates that the target gene shows the same pattern as the query gene. Negative 
indicates that the target gene shows the inversed pattern as the query gene.  
c BEST indentifies all six genes among six target genes in RegulonDB. ―X‖ indicates that 
the predicted gene is in the RegulonDB target set.  

































Table A2.7 Information on the 31 potential LexA target genes identified by BEST in the 
100-gene test set extracted from the E. coli compendium  
 
Rank Gene Namea Log Bayes Ratio positive/negativeb RegulonDBc CLRd 
1 dinF 370.20 
 
X X 
2 araB 365.72 
   3 araA 365.42 
   4 araE 359.80 
   5 araD 358.89 
   6 ymfJ 349.63 
   7 ymfL 347.87 
   8 recN 347.63 
 
X X 
9 xisE 339.91 
   10 yebG 333.06 
  
X 
11 ymfT 332.53 
   12 dinI 320.63 
  
X 
13 recX 318.60 
   14 umuD 316.82 
 
X X 
15 tisB 314.57 
   16 yafN 314.26 
  
X 
17 tisA 312.63 
   18 dinD 312.63 
  
X 
19 uvrA 310.18 
 
X X 
20 dinG 308.19 
  
X 
21 yafO 306.66 
  
X 
22 sulA 305.85 
 
X X 
23 polB 299.75 
 
X 
 24 recA 292.55 
 
X X 
25 umuC 289.20 
 
X X 
26 dinB 282.91 
   27 bssS 262.57 
   28 ssb 262.39 
 
X 
 29 uvrD 259.91 
 
X 
 30 yebF 242.58 
  
X 
31 uspE 239.61 negative     
 
a Genes displayed here are sorted by Log Bayes ratio (target gene versus non-target gene). 
b Blank indicates that the target gene shows the same pattern as the query gene. Negative 




c BEST indentifies ten genes among 16 target genes in RegulonDB. ―X‖ indicates that the 
predicted gene is in the RegulonDB target set.  


































Table A2.8 Information on the 54 potential FlhC target genes identified by BEST in the 
200-gene test set extracted from the E. coli compendium  
 
Rank Gene Namea Log Bayes Ratio positive/negativeb RegulonDBc CLRd 
1 flgE 422.41 
 
X X 
2 fliA 417.80 
 
X X 
3 flgC 415.00 
 
X X 
4 flgB 412.97 
 
X X 
5 flgG 406.95 
 
X X 
6 flgH 406.29 
 
X X 
7 flgD 403.29 
 
X X 
8 flhD 401.18 
  
X 
9 motB 398.98 
  
X 
10 fliL 398.54 
 
X X 
11 fliN 398.03 
 
X X 
12 flgI 397.19 
 
X X 
13 flgK 396.32 
  
X 
14 flgA 396.03 
 
X X 
15 fliK 389.85 
 
X X 
16 fliM 388.79 
 
X X 
17 flgF 388.45 
 
X X 
18 motA 387.71 
  
X 
19 cheA 386.19 
  
X 
20 cheW 385.20 
  
X 
21 fliZ 384.50 
 
X X 
22 fliJ 384.25 
 
X X 
23 flgM 382.36 
  
X 
24 fliF 382.00 
 
X X 
25 flgN 380.73 
  
X 
26 fliS 380.29 
  
X 
27 cheY 378.15 
  
X 
28 flgJ 372.04 
 
X X 
29 cheZ 371.92 
  
X 
30 cheR 371.27 
  
X 
31 yecR 370.70 
  
X 
32 cheB 369.11 
  
X 
33 fliG 367.55 
 
X X 
34 fliC 366.59 
  
X 
35 flgL 366.38 
  
X 






37 fliD 360.82 
  
X 
38 fliP 356.28 
 
X X 
39 fliQ 350.16 
 
X X 
40 tar 347.51 
  
X 
41 fliI  345.24 
 
X X 
42 ycgR 344.20 
  
X 
43 tap 338.41 
  
X 
44 fliE 326.37 
 
X X 
45 flxA 325.67 
  
X 
46 fliO 324.78 
 
X X 
47 ymdA 314.15 
  
X 
48 flhA 301.22 
 
X X 
49 flhE 300.16 
 
X X 
50 flhB 290.68 
 
X X 
51 fliR 275.89 
 
X X 
52 yhjH 272.24 
  
X 
53 tsr 255.05 
  
X 
54 yjdA 206.14 
 
    
 
a Genes displayed here are sorted by Log Bayes ratio (target gene versus non-target gene). 
b Blank indicates that the target gene shows the same pattern as the query gene. Negative 
indicates that the target gene shows the inversed pattern as the query gene.  
c BEST indentifies 29 genes among 30 target genes in RegulonDB. ―X‖ indicates that the 
predicted gene is in the RegulonDB target set.  















Table A2.9 Information on the 67 potential FlhD target genes identified by BEST in the 
200-gene test set extracted from the E. coli compendium  
 
Rank Gene Namea Log Bayes Ratio positive/negativeb RegulonDBc CLRd 
1 flhC 333.41 
  
X 
2 flgE 312.18 
 
X X 
3 flgB 311.50 
 
X X 
4 flgH 311.46 
 
X X 
5 fliA 311.18 
 
X X 
6 flgC 310.34 
 
X X 
7 flgG 307.33 
 
X X 
8 flgD 299.71 
 
X X 
9 flgK 299.55 
  
X 
10 flgI 299.12 
 
X X 
11 fliZ 298.07 
 
X X 
12 flgA 296.58 
 
X X 
13 motB 294.72 
  
X 
14 cheW 293.40 
  
X 
15 flgF 293.22 
 
X X 
16 fliN 292.68 
 
X X 
17 fliL 292.29 
 
X X 
18 flgN 291.93 
  
X 
19 fliF 290.99 
 
X X 
20 flgM 290.12 
  
X 
21 fliM 288.74 
 
X X 
22 cheA 288.54 
  
X 
23 fliK 285.84 
 
X X 
24 fliS 282.94 
  
X 
25 motA 282.93 
  
X 
26 yecR 282.39 
  
X 
27 flgL 281.34 
  
X 
28 fliJ 279.79 
 
X X 
29 fliC 275.71 
  
X 
30 flgJ 275.32 
 
X X 
31 fliD 271.73 
  
X 
32 cheR 271.62 
  
X 
33 fliP 270.94 
 
X X 
34 fliG 270.80 
 
X X 
35 cheB 269.55 
  
X 
36 cheY 269.30 




37 fliH 264.98 
 
X 
 38 tar 264.64 
  
X 
39 cheZ 264.38 
   40 fliE 260.07 
 
X X 
41 fliI  256.40 
 
X X 
42 ycgR 251.77 
  
X 
43 flxA 251.29 
   44 fliQ 251.26 
 
X X 
45 flhE 231.94 
 
X 
 46 fliO 229.43 
 
X X 
47 flhB 222.84 
 
X 
 48 flhA 221.21 
 
X X 
49 ymdA 218.56 
  
X 
50 fliR 196.03 
 
X X 
51 tsr 192.51 
  
X 
52 yibT 191.41 
   53 yhjH 191.29 
  
X 
54 yjbJ 188.62 
   55 hdeB 187.86 
   56 slp 184.57 
   57 ompF 181.05 
   58 micF 178.49 negative 
  59 gadE 178.32 negative 
  60 hdeA 177.08 
   61 hdeD 176.26 
   62 gadX 173.90 
   63 gadB 171.77 
   64 gadA 165.48 
   65 yjdA 148.57 
   66 bssS 122.36 
   67 ygiW 109.00 
 
    
 
a Genes displayed here are sorted by Log Bayes ratio (target gene versus non-target gene). 
b Blank indicates that the target gene shows the same pattern as the query gene. Negative 
indicates that the target gene shows the inversed pattern as the query gene.  
c BEST indentifies 29 genes among 46 target genes in RegulonDB. ―X‖ indicates that the 
predicted gene is in the RegulonDB target set.  




Table A2.10 Information on the 56 potential FliA target genes identified by BEST in the 
200-gene test set extracted from the E. coli compendium  
 
Rank Gene Namea Log Bayes Ratio positive/negativeb RegulonDBc CLRd  
1 fliZ 524.28 
 
X X 
2 flgE 520.41 
 
X X 
3 flgC 518.79 
 
X X 
4 flgB 510.76 
 
X X 
5 flgG 506.72 
 
X X 
6 flgD 506.65 
 
X X 
7 flgN 503.87 
  
X 
8 flgK 503.51 
  
X 
9 flgH 490.47 
 
X X 
10 flgM 488.91 
  
X 
11 fliD 484.75 
 
X X 
12 cheW 484.68 
 
X X 
13 cheA 480.61 
 
X X 
14 motB 470.69 
 
X X 
15 motA 469.88 
 
X X 
16 flgL 469.11 
 
X X 
17 flgA 467.86 
  
X 
18 fliK 463.84 
 
X X 
19 fliS 459.14 
 
X X 
20 fliN 456.92 
 
X X 
21 flgF 456.74 
 
X X 
22 cheZ 453.19 
 
X X 
23 cheR 452.47 
 
X X 
24 fliL 452.27 
 
X X 
25 fliJ 452.03 
 
X X 
26 flgI 448.03 
 
X X 
27 cheB 443.04 
 
X X 
28 tar 439.80 
  
X 
29 fliC 439.60 
  
X 
30 fliF 435.47 
 
X X 
31 fliM 431.91 
 
X X 
32 fliG 429.41 
 
X X 
33 cheY 425.70 
 
X X 
34 flgJ 423.63 
 
X X 
35 fliP 420.70 
 
X X 






37 ycgR 415.26 
  
X 
38 tap 414.20 
 
X X 
39 fliQ 404.20 
 
X X 
40 fliH 389.79 
 
X X 
41 flxA 377.76 
 
X X 
42 fliT 369.77 
 
X X 
43 ymdA 364.62 
  
X 
44 fliO 361.51 
 
X X 
45 fliI  355.28 
 
X X 
46 fliE 354.40 
 
X X 
47 flhC 348.31 
  
X 
48 flhB 335.53 
 
X X 
49 flhE 321.02 
 
X X 
50 flhA 317.85 
 
X X 
51 fliR 312.35 
 
X X 
52 yhjH 310.92 
  
X 
53 flhD 305.93 
  
X 
54 tsr 281.05 
  
X 
55 ves 233.09 
  
X 
56 yjdA 187.37 
 
  X 
 
a Genes displayed here are sorted by Log Bayes ratio (target gene versus non-target gene). 
b Blank indicates that the target gene shows the same pattern as the query gene. Negative 
indicates that the target gene shows the inversed pattern as the query gene.  
c BEST indentifies 41 among 42 target genes in RegulonDB. ―X‖ indicates that the 
predicted gene is in the RegulonDB target set.  













2.5.6 Figures in appendix 
Figure A2.1 ROC curves for various query methods when applying to synthetic datasets 
simulated under different settings and when there are 100% foreground columns. BEST 
A default setting; BEST B allowing exclusion of individual cells from the foreground; 
BEST C fixing the indicator variables of five true target genes and five true experimental 
conditions as 1. A. No linear transformation nor cell- level noise. B. With linear 
transformation only. C. With cell- level noise only. D. With both linear transformation 







Figure A2.2 ROC curves for various query methods when applying to synthetic datasets 
simulated under different settings and when there are 75% foreground columns. BEST A 
default setting; BEST B allowing exclusion of individual cells from the foreground; 
BEST C fixing the indicator variables of five true target genes and five true experimental 
conditions as 1. A. No linear transformation nor cell- level noise. B. With linear 
transformation only. C. With cell- level noise only. D. With both linear transformation 







Figure A2.3 ROC curves for various query methods when applying to synthetic datasets 
simulated under different settings and when there are 50% foreground columns. BEST A 
default setting; BEST B allowing exclusion of individual cells from the foreground; 
BEST C fixing the indicator variables of five true target genes and five true experimental 
conditions as 1. A. No linear transformation nor cell- level noise. B. With linear 
transformation only. C. With cell- level noise only. D. With both linear transformation 








Figure A2.4 Log-likelihood trace plots of the ten parallel chains resulted from the BEST 
run on 100-gene and 300-gene test sets selected from the E. coli microarray compendium. 
 
 
Figure A2.5 Sequence logo plot (52) and position specific weight matrix (PSWM) for the 
motif of transcription factor Lrp. Lrp motif is downloaded from regulonDB: 
http://regulondb.ccg.unam.mx/data/Matrix_AlignmentSet.txt. The logo plot was 
generated by the seqLogo program (53).  
 
Position 1 2 3 4 5 6 7 8 9 10 11 12 13 
A 11 14 27 14 21 11 10 37 6 6 8 12 0 
C 2 7 3 7 0 0 7 10 12 15 35 1 1 
G 28 13 3 0 11 8 4 0 8 11 10 10 33 





Figure A2.6 Boxplots of Pearson correlation coefficients. A. Boxplots of Pearson 
correlations between expression profiles of the 61 experimentally verified Lrp target 
genes and Lrp. The left one summarize correlations measured in the 162 background 
experiments and the right one summarize correlations measured in the 143 foreground 
experiments. A paired t-test comparing the two sets of correlation coefficients returns a p-
value of 0.0079. B. Boxplots of Pearson correlations between expression profiles of the 
28 genes BEST indentified as Lrp target. The left one summarize correlations measured 
in the 162 background experiments and the right one summarize correlations measured in 
the 143 foreground experiments. A paired t-test comparing the two sets of correlation 
coefficients returns a p-value of 1.948×10-12. 
 















Figure A2.7 A. Histograms of expression profile differences (zij) in the top five 
experimental conditions (foreground). B. Histogram of expression profile differences (zij) 
in the bottom five experimental conditions (background). Data used here is the 100-gene 
test set selected from the E. coli microarray compendium. 
   A.                        B. 












A.                        B. 






Figure A2.8 Trace plots of 24 predicted Lrp target genes identified by BEST that are not 
in the RegulonDB target set. Black lines indicate the query gene—Lrp, the red line 
indicate the potential target genes. Only the 139 foreground experimental conditions 






























Figure A2.9 A. Histograms of expression profile differences (zij) in the top five 
experimental conditions (foreground). B. Histogram of expression profile differences (zij) 
in the bottom five experimental conditions (background). Data used here is the 300-gene 
test set selected from the E. coli microarray compendium. 
 
   A.                        B. 











A.                        B. 
  





CHAPTER 3  
 





 Accurately locating the transcription factor (TF)-DNA interaction sites provides 
key insights into the underlying mechanisms of transcriptional regulation. By exploiting 
the fact that binding sites for a specific TF often show sequence specificity, 
computational prediction of TF binding sites, or motif finding, has become an 
indispensible tool for functional genomics research. A variety of different software 
programs have been developed for motif- finding (44,54-59) (see Tompa et al. (60) for a 
review of this topic).  
 The input data for computational motif- finding algorithms are DNA sequences 
believed to be enriched by the TF binding sites, or motifs. Typical sources of the input 
data are known co-regulated genes (59), phylogenetic conservation (61), or results from 
functional genomics experimental assays (54,62-64). For the latter, continually evolving 
high-throughput technologies, from DNA microarray (1,11) to ChIP-chip (65,66) and 




 ChIP-Seq, or chromatin immunoprecipitation (ChIP) (70,71) followed by ultra-
high-throughput sequencing, has emerged as a powerful new techno logy for genome-
wide mapping of protein-DNA interactions and histone modifications (4,67-69). Through 
direct sequencing of all DNA fragments from ChIP assays, ChIP-Seq can reveal protein-
DNA interaction sites across the entire genome, thus building a comprehensive and high-
resolution interactome map for DNA-binding proteins of interest.  
 From past experience, exploiting the quantitative information provided by high-
throughput genomic assays allows scientists to develop more effective motif- finding 
algorithms. Improvements in motif detection have been reported in studies using 
microarray (62,63) and ChIP-chip (54,64) data. The newly emerged ChIP-Seq technology 
has demonstrated remarkable sensitivity and specificity in identifying protein-DNA 
binding loci across the entire genome with high resolution and few constraints. In excess 
of 10,000 DNA sequences are routinely being identified as candidates that potentially 
harbor protein-DNA interaction sites of interest. Such information provides an exciting 
new venue for motif discovery and refinement.  
  A de novo motif search is a natural follow-up to the identification of ChIP-
enriched regions. Not only is it required when the TF binding motif pattern is unknown, it 
is also important in cases where TF and its canonical binding motif pattern have been 
established. After all, it is reassuring to be able to ―rediscover‖ the known TFBS motif 
pattern from the input sequences. More importantly, most of the known TF binding motif 
patterns stored in the various TF binding motif databases or reported in the literature are 
defined based on limited numbers of experimentally verified TF-DNA interaction sites. 




Performing a de novo motif search on a large number of ChIP-Seq binding sites has the 
potential to refine the motif patterns of the TFBS.  
 While a variety of methods that attempt to identify ChIP-enriched genomic 
regions from ChIP-Seq experiments (also called ―peak calling‖) have been described (72-
80), little has been developed utilizing ChIP-Seq data for motif finding.  
 Probability model-based de novo motif finding algorithms such as MEME have 
demonstrated a high level of sensitivity and specificity (44,55-57,81-85). However, since 
these methods were developed when only a handful of motif-enriched sequences were 
available, they do not work well when analyzing large sets of sequences identified by 
ChIP-Seq. There are at least two limitations that affect their performance: (1) the 
requirement for going through all bases in all sequences using time-consuming iterative 
procedures means that these methods do not scale well for the analysis of large sets of 
sequences generated from ChIP-Seq; (2) existing methods, which only consider sequence 
data, are unable to fully utilize the rich information produced from ChIP-Seq. Overlooked 
information includes the sequencing depth along the ChIP-enriched regions and the 
overall significance of ChIP-enrichment for each sequence. ―Sequencing depth‖ refers to 
the number of ChIP DNA fragments that cover each base. Currently, a common practice 
for performing motif finding on ChIP-Seq data is to use existing motif- finding tools on a 
subset of all sequences (e.g., the top 500 sequences or top 10% of all such sequences) 
(74,75). This is sub-optimal because the small sample size may lead to an inaccurate 





 We believe that a more desirable approach is to develop algorithms that can 
utilize all of the sequence information generated from ChIP-Seq. Not only will this 
strategy result in the identification of more accurate motif patterns, but we also predict 
that the dramatically increased number of in vivo binding sites revealed by ChIP-Seq will 
permit the use of probability models that are more sophisticated than the commonly-used 
product multinomial models (83) for characterizing the motif pattern.  
  To address these limitations and fully exploit the information provided by ChIP-
Seq experiments, we develop a novel model-based motif- finding algorithm named the 
Hybrid Motif Sampler (HMS). It is specifically designed for ChIP-Seq data and utilizes 
all ChIP-enriched regions identified from ChIP-Seq experiments. In this algorithm, we 
propose a new probability model that considers both DNA sequence and sequencing 
depth information that is available from ChIP-Seq experiment. It also allows inter-
dependent positions within a motif to be identified. In addition, we propose a novel 
hybrid searching scheme to significantly expedite the iterative procedure. Our algorithm 
is capable of processing tens of thousands of sequences and is much faster than the 
established de novo motif- finding tools such as MEME. 
3.2 Methods  
3.2.1 The statistical model 
 Let  denote a set of  sequences (e.g., DNA sequences in ChIP-
enriched regions identified by ChIP-Seq) of length . We initially assume that 
every sequence  contains exactly one binding site. In addition, the vector that is formed 
by the start locations is referred to as the alignment variable, denoted as  




known.  Given  and , the aligned sequence motif can be represented by a four by  
matrix. Each column of the matrix stores the frequency counts of the four types of 
nucleotides. Liu et al. (83) proposed the product-multinomial model to model the 
nucleotide preferences shown in such matrices. The product-multinomial model has been 
widely used in EM-based (57,81) and Gibbs sampler-based (56,82,84) motif finding 
algorithms. Let ,  represent the nucleotide preference at the  th 
position of the motif and let the probability vector  represent the nucleotide preference 
for non-motif positions in these sequences. Each of the  is a 
probability vector of length four. For notational simplicity, we use integers 1, 2, 3 and 4 
to represent the four types of nucleotides A, C, G and T.  
 For de novo motif finding, the parameter of main interest in our model is the 
alignment variable . Lawrence et al. (56) proposed a Gibbs sampler-based approach in 
which the posterior distribution for alignment  can be expressed as: 
 
                                                                                                                                          
 
 (3.1) 
Where  and the functions , returns the 
number of nucleotides of type . 
 For and , an alternative to sampling them from posterior conditional 
distributions as in a standard Gibbs sampler, one can use the predictive updating 




approximate the updated parameters during iteration. More details of these strategies can 
be found in Liu et al. (83) 
3.2.2 Allowance for some sequences that do not contain the motif  
 In the model above, we assume that every sequence  contains exactly one motif. 
However, this is not the case in real ChIP-Seq data. To increase specificity, it is highly 
desirable that we generalize the method to allow some sequences to be motif- free. We 
introduce a binary indicator variable  where   indicates that  contains at least 
one motif, and  otherwise. In the algorithm,  is set to 1 if the average of likelihood 
ratios observing the motif in the sequence , denoted as , is greater than 1. i.e.,  
                                                                                                                                          
  
(3.2) 
After updating , we only conduct motif search on the sequences with .  
3.2.3 Modeling sequencing depth 
 The model described in equation (3.1) assumes that binding motifs are equally 
likely to occur at all positions in each sequence. This is reasonable when no information 
beyond the input DNA sequences is considered. However, such a model is no longer 
sufficient for analyzing ChIP-Seq data since additional information beyond the DNA 
sequences is available and should be incorporated. In particular, it has been shown that 
the sequencing depth in each ChIP-enriched region is indicative of the motif location 
(74,77). Figure A3.1 in appendix shows that: the majority of motifs are tightly packed 
near the peak summit (the location inside each peak with the highest sequence coverage 




 To capitalize on the extra information provided by ChIP-Seq, we propose adding 
to the method an informative prior distribution of the motif location based on the 
sequencing depth. There are multiple ways to assign such priors. The simplest strategy is 
to make the prior probabilities directly proportional to the sequencing depth in each 
sequence. However, since sequencing depth is affected by many factors, such as local GC 
content, using a prior distribution like this may result in ―over fit ting‖. Alternatively, a 
parametric distribution that approximates the sequencing depth can be used to obtain the 
prior probabilities. In this study, we set the prior probabilities to be proportional to a 
discretized Student’s -distribution with three degrees of freedom and rescaled such that 
the prior probabilities form a step function with a fixed step-size (25 bp in this study). 
The prior probabilities are symmetric and centered at the peak summit (most peak-calling 
software provides the exact location of the summit). Specifically, the prior probabilities 
that a motif starts at position  can be expressed as: 
                                                                                                                                          
 
 (3.3) 
Where  is the probability density function of the Student’s -distribution with three 
degrees of freedom,  is the location of the peak summit,  is the motif width,  is the 
step size (25 bp in this study) in the step function and int ][  returns the integer part of a 
real number. Please see Figure A3.2 in appendix for an illustration of the prior 
probabilities. The reason that we choose Student’s -distribution instead of a normal 
distribution is because it better allows for some motif locations to be far from the peak 
(the standard deviation of Student’s -distribution with three degrees of freedom is 1.73, 




3.2.4 Modeling intra-motif dependency 
 The classical product-multinomial model assumes that the positions within the 
motif are independent of each other (86). However, recent studies indicate that some 
positions of TF binding motifs exert an inter-dependent effect on the binding affinities of 
TF’s (87-90). These findings imply that the commonly used product-multinomial model 
may be too simplistic in characterizing the binding sites. Models that allow for dependent 
positions likely will provide a better fit of the data. The significantly increased quantity 
of motifs identified by ChIP-Seq enables us to consider a more sophisticated model that 
can take into account the intra-motif dependency. 
 There have been numerous attempts to incorporate into models the inter-
dependency among positions within a motif. King and Roth (91) introduced a non-
parametric representation of motifs that allows arbitrary dependencies among positions. 
Barash et al. (92) suggested multiple Bayesian network models to represent dependencies 
among motif positions. Zhou and Liu (93) proposed a generalized weight matrix model in 
which a 16-component multinomial model is used to model two dependent positions 
jointly. 
 Here we extend the generalized weight matrix model of Zhou and Liu. To take 
greater advantage of the abundant sequence information made available by the ChIP-Seq 
technology, our model allows up to three positions to be inter-dependent. 
3.2.5 Detection of dependent positions 
 Given a set of aligned putative binding motifs, our goal is to identify positions 
that show inter-dependency. Here ―inter-dependency‖ implies conservation of nucleotide 




independent motif model. As an example, for a pair of positions, if the frequency of a 
particular dinucleotide, say AC, is much higher or lower than the product of frequency of 
nucleotide A in the first position and frequency of nucleotide C in the second position, we 
conclude that the two positions are dependent.  
 A variety of methods have been proposed in the literature to search for such inter-
dependent positions. Barash et al. (92) applied machine learning approaches to infer the 
structure of a Bayesian network that best represents the underlying motif. Zhou and Liu 
(93) proposed a Metropolis-type iterative procedure to identify pairs of inter-dependent 
positions. Given the abundant motif data from ChIP-Seq, we implement a comprehensive 
search strategy to go through all pairs of positions within the motif to determine whether 
there is evidence of dependency. To be specific, for any two positions  and  among 
 possible pairs, we first obtain probability estimates of the 16 dinucleotides 
assuming either a 16-component multinomial model (dependent) or the product of two 
four-component multinomial models (independent). Let the number of motifs be 
represented by . The term  represents the number of motifs whose  th position is 
occupied by nucleotide x and the term  represents the number of motifs whose  
th and  th positions are occupied by nucleotides x and y respectively. The probability 
estimates under the two competing models are  and 
, respectively. We then calculate the Hamming distance between the two 
sets of estimates as  






Under the hypothesis that the two positions are independent, we expect that 
distance , excluding sampling variability; larger  indicates stronger inter-
dependency between positions  and . In this study, we designate positions  and  to be 
dependent if . The threshold is determined from the empirical null distribution 
of  inferred through simulations. More details can be found in appendix. 
3.2.6 Posterior distribution 
We take a Bayesian approach and consider two different models to describe the 
motif pattern. In the first one, we assume all positions within the motif are independent. 
There are two sets of parameters in this model: alignment variable  and multinomial 
distribution probability vector . The prior distributions for  are 
multinomial with probabilities defined as in equation (3.3). Adopting a conjugate prior 
distribution for each , which is , the posterior probabilities that 
a motif starts at position  can be expressed as: 
                                                                                                                                          
 
 (3.5) 
As suggested in Liu et al. (83), the above conditional distribution can be closely 
approximated by replacing  by its posterior mean given the current alignment vector 
: 
                                                                                                                                          
 
 (3.6) 
For background (non-motif) regions, it has been shown that employing a Markov model 
to capture weak dependency in background DNA sequences improves the sensitivity and 




study, we use a third-order Markov model as in Liu et al. (55) to characterize the 
background sequences. Under such a model, the probability of observing DNA sequence 
fragment   in the background can be represented by 
 
                                                                                                                                           (3.7) 
 In this background model, the conditional probabilities are 
estimated from human promoter sequences downloaded from UCSC genome browser 
website (http://hgdownload.cse.ucsc.edu/goldenPath/hg18/bigZips/). The dataset contains 
5kb upstream sequences of annotated transcription starts for all RefSeq genes with 
annotated 5' UTRs.  
 After incorporating these modifications, the complete posterior distribut ion for 
  becomes 
  (3.8) 
 In the second model, we consider intra-motif dependency. Within the motif, we 
assign positions into two disjoint groups: groups of independent positions S and groups of 
dependent position pairs P where . By modeling dependent 
positions jointly, the probability ―matrix‖  becomes an amalgam of vectors of length 
four (modeling single positions) and vectors of length 16 (modeling pairs of dependent 
positions). The prior distributions for the two types of  ’s are   
and  respectively. The complete posterior 






  (3.9) 
Here the counting function , whose argument is a set of positions, counts the 
frequency of the 16 dinucleotides for a pair of positions within the motif. The above 
model can be extended easily to allow three-way inter-dependent positions.   
3.2.7 Acceleration via prioritized hybrid Monte Carlo 
 To streamline this motif- finding algorithm in order to handle a large number of 
input sequences, we develop a prioritized hybrid strategy to increase computation speed 
with only minimal if any sacrifice in accuracy. Unlike a standard Gibbs sampler where 
motif alignment variables are sampled stochastically from all sequences, only a small 
proportion, , of all sequences are subjected to stochastic sampling. For the remaining 
sequences, we select the alignment variable deterministically by identifying the position 
that corresponds to the highest probability as given by equation (3.8) or (3.9). Since the 
deterministic approach is much faster than the stochastic one and the proportion  we use 
is often quite small (  ~10%), this hybrid strategy is much faster than the standard Gibbs 
motif sampler (56). 
For each iteration, the proportion of sequences undergoing stochastic search is 
constant, but a different set of sequences is selected each time. We have automated the 
process of selecting a subset of sequences for stochastic search. All the sequences 
identified from the ChIP-Seq experiment are rank-ordered according to their ChIP-




sample a fixed number of  sequences from a multinomial distribution 
. At the beginning of the iteration, we use a monotonically decreasing 
triangle probability distribution, which assigns higher probability to sequences with 
higher ChIP-enrichment. As the iteration proceeds, the slope of the triangle gradually 
becomes flatter so that the oversampling of higher ChIP-enriched sequences diminishes. 
In the last iteration, the distribution becomes uniform. For the  th iteration, we have 
  (3.10) 
3.2.8 Implementation 
 We have developed a software program that implements the algorithms described 
in this manuscript. The HMS program is a Gibbs sampler type iterative procedure. To 
reduce the possibility that the Markov chain converged to a local mode, we run multiple 
Markov chains and choose the motif pattern that corresponds to the highest likelihood as 
the final motif pattern. The number of parallel chains and the number of complete 
iterative cycles within each chain are specified by users. Within each chain, the iterative 
procedure can be broken down into three steps. In the first step, we use a traditional 
product multinomial model in which all positions are assumed independent of each other. 
We further assume every sequence contains one motif. In the second step, we again 
assume all positions are independent, but we allow some sequences to be motif- free. In 
the final step, we adopt the generalized motif model that allows intra-motif dependency. 





3.2.9 Performance evaluation using simulated data 
 In the simulation study, we are interested in evaluating the performance of various 
de novo motif finding algorithms from two perspectives: first, the number of times a 
program successfully detects the motif inserted into each of the 100 simulated datasets; 
second, the accuracy of the inferred motif pattern given that the motif has been found.  
 For the former, since we know the true location of all inserted motifs in the 
simulated datasets, we are able to directly verify whether each motif site predicted by the 
testing software is correct. Within each simulated dataset, we declare that the inserted 
motif is found if the proportion of sequences in which the program correctly identifies the 
true motif location is greater than 20%.  
For the latter, we measure the accuracy of an inferred motif pattern by calculating 
the average Hamming distance between the true probability matrix  and its prediction 
denoted as  : 
  (3.11) 
3.2.10 Performance evaluation using real data 
 Given a set of sequences identified by ChIP-Seq, we want to discern which de 
novo motif- finding algorithm produces a more accurate motif pattern. Since the exact true 
motif pattern is unknown, we use motif enrichment as the criterion. We assume that 
among multiple motif patterns, the one that is most enriched in the ChIP-Seq-identified 
regions relative to random controls is closest to the true motif pattern. 
 We use a cross-validation scheme to assess motif enrichment. The original dataset 




restricted to within 200 bp in length and centered at the peak summit (no more than 100 
bp toward each side of the peak summit). For the testing set, we create a control set 
composed of randomly selected DNA promoter sequences (within 5kb upstream of the 
transcription start site) as in Zhou and Liu (93) matched by number of sequences and 
length of each sequence. We run each motif- finding program on the training set to 
identify the motif pattern, and then utilize this pattern to scan both the testing and the 
corresponding control sets to assess how many sequences contain the motif. We employ a 
set of significance thresholds and calculate the corresponding empirical false discovery 
rate (FDR) (94) and motif enrichment, as measured by Chi-square test statistics for a 
 contingency table. The empirical FDR is estimated by dividing the number of 
control sequences that contain the motif by the number of testing sequences that contain 
the motif. We repeat the scheme five times for each dataset and report the average test 
statistics corresponding to each FDR level.  
We plot the curves of the empirical FDR versus the Chi-square test statistics when 
the empirical FDR is between 0 and 0.2. To accomplish this, we equally divide the 
empirical FDR into ten consecutive windows and calculate the mean of the Chi-square 
test statistics from five cross validations (when the corresponding empirical FDRs fall 
into the same window). Since the curve representing the most enriched motif pattern will 
be the highest, we use area under the curve (AUC) as a quantitative assessment of the 
overall motif enrichment. Higher AUC indicates further motif enrichment.  
3.2.11 Estrogen receptor ChIP-Seq experiment on MCF7 cells 
 To test the algorithms in a real setting, we have conducted a ChIP-Seq experiment 




cell line. ER is a hormonal TF that, when liganded by estrogen, binds specially to 
estrogen response elements (ERE) and plays a critical role in breast cancer development. 
Identifying ER target genes and refining the ERE motifs are thus of significant interest. A 
brief description of the experimental protocol is shown in the next paragraph. More 
details can be found in appendix. 
 Briefly, MCF-7 cells were grown in RPMI media supplemented with 10% FBS to 
50% confluence. The cells were then hormone-starved for three days prior to treatment of 
the vehicle control or 10nM β–estradiol for 45 minutes. The cells were then harvested for 
ChIP analysis using an antibody against estrogen receptor (ER)-alpha (sc-543x, Santa 
Cruz) or against IgG. The ChIP-enriched DNA was evaluated for significant enrichment 
of positive control genes and then subjected to ChIP-Seq sample preparation and short-
read sequencing using Illumina Genome Analyzer (Illumina Inc, San Diego, CA) 
following the manufacturer’s protocols. The raw sequencing images were analyzed using 
the Illumina analysis pipeline, and the sequencing reads were subsequently aligned to the 
human reference genome (NCBI v36, hg18) using ELAND software (Illumina Inc, San 
Diego, CA), producing sequencing reads of 35 bps. Only sequencing reads that are 
uniquely mapped to the human reference genome with up to two mismatches were 
included for further analysis as delineated in this study. We used the HPeak software 
program (95), to define the ChIP-enriched regions. Details of the HPeak software 





3.3.1 Simulation study 
3.3.1.1 Independent motif models 
 The goal of this simulation study was to evaluate the ability of HMS to identify 
the correct motif patterns. We use the default setting for HMS which adopts the 
informative prior and allows intra-motif dependency. For comparison, we also tested a 
simpler version of HMS that assumes all positions are independent. In addition, we 
applied two established motif- finding software tools, MDscan (54) and MEME (57) on 
the same sets of simulated data. Following the simulation scheme of Liu et al. (54), four 
motif models were manually created (Table A3.1A), representing two different motif 
widths (8 bps and 16 bps), and two different degrees of conservation measured by 
information content (1.42 and 0.93). The information content is defined as:  
  (3.12) 
where  is the proportion of base  at the motif position . Information content ranges 
from 0 to 2, reflecting the weakest to the strongest motifs. Finally, two different motif 
abundance schemes (Table A3.1B) were considered for a total of eight combinations in 
the simulation study. The eight simulation settings covered a wide range of scenarios. 
The combination of short motif width, weak motif information content and low motif 
abundance was the most challenging. 
 For each setting, we simulated 100 test datasets. Each dataset contains 3,000 
sequences of 200 bp in length. To mimic real human data, all the sequences were 




collection of 5kb promoter sequences of annotated genes in the human genome 
(http://hgdownload.cse.ucsc.edu/goldenPath/hg18/bigZips/). Hypothetical motifs were 
generated from product multinomial models with specified length and information 
content. The proportion of sequences that contained a motif followed one of the two 
abundance schemes mentioned in the previous paragraph. We assumed that each 
sequence contained at most one motif.  
 We next derived the empirical distribution from real ChIP-Seq data of CTCF 
and NRSF of the motif start locations in a 200 bp window centered at the peak summit. 
We strategically inserted the motifs in these sequences following this empirical 
distribution.  As a consequence, the motif locations were biased toward the center of the 
sequence, which was assumed to be the location of the peak summit.  
 We applied MDscan, MEME and HMS to every dataset. Two versions of HMS 
were used in the comparison. One assumed an informative prior (proportional to a 
discretized and rescaled Student’s -distribution with three degrees of freedom) that 
favored motif start locations near the peak. The other, denoted as HMS_uniform, 
assumed a uniform prior for the motif start location throughout the genome. As described 
in the Methods section, we used the successful motif detection rate and the accuracy of 
predicted motif pattern as measurements of performance.  
 For the motif detection rate, both versions of HMS achieved perfect results in all 
eight simulation settings. MEME and MDscan achieved perfect results in six and four 
settings respectively. MEME achieves equal or higher detection rate than MDscan in all 





Figure 3.1 Performance comparison on simulated data with independent and dependent 
motif model. The y-axis represents the difference between two sets of discrepancies 
resulted from two different motif finding methods. The discrepancies are measured by the 
average Hamming distance between the estimated and the true probability matrix . A. 
Independent, motif width = 8 bp. B. Independent, motif width = 16 bp. C. Dependent, 
motif width = 8 bp. D. Dependent, motif width = 16 bp.  
A. Independent, motif width = 8 bp. 
 




























C. Dependent, motif width = 8 bp. 
 
D. Dependent, motif width = 16 bp. 
 
 We next compared performance on motif pattern prediction accuracy. The 
prediction accuracy is defined as the discrepancy between predicted and true  for each 
method and each dataset. See equation (3.11) for the expression for the discrepancy. To 































discrepancies obtained using HMS and that of a competing method (HMS_uniform, 
MEME and MDscan). Among the 100 datasets, we only considered the ones in which all 
methods successfully detected the right motif. Significantly smaller discrepancy (p-value 
<0.01) was observed in six out of eight simulation settings when comparing HMS to 
MEME, and in seven out of eight settings when comparing HMS to MDscan (Figure 
3.1A, Figure 3.1B and Tables A3.2A in appendix). In addition, we found that adopting 
the informative prior for the proposed HMS method results in more accurate motif 
pattern prediction in all eight simulation settings than when using the uniform prior. 
(Tables A3.2A in appendix).           
3.3.1.2 Inter-dependent motif models 
 We next conducted simulation studies to evaluate the performance of HMS when 
some positions within the motif showed inter-dependency. In our simulation, dependency 
was added to two pairs of positions in the 8 bp motif model and four pairs of positions in 
the 16 bp motif model. The joint distribution of the pairs was taken from the one 
predicted for position pair (1,2) in the E2F motif in Zhou and Liu (93) (as shown in 
Figure 2(b) in the original paper, reproduced in Table A3.3 in appendix).  
 In terms of motif detection, both versions of HMS achieved perfect results in five 
out of the eight simulation settings. MEME and MDscan achieved perfect results in four 
and two settings respectively. Furthermore, HMS and HMS_uniform reported higher 
detection rates compared to MDscan and MEME in all simulation settings. Our results 
also suggest that the HMS method assuming informative prior performed better than the 




When comparing motif pattern prediction accuracy, paired t-tests showed that 
motif pattern prediction discrepancies were significantly smaller for HMS than MEME 
and MDscan in all testable simulation settings (MEME did not identify the correct motif 
in any dataset under two simulation settings; MDscan only identifies the correct motif in 
two out of 100 datasets under one simulation settings. Therefore no paired t-test is 
performed for those simulation settings).  The performance was similar between the two 
versions of HMS (Figure 3.1C, Figure 3.1D and Table A3.2B in appendix). 
3.3.2 Real data 
 To further evaluate the performance of HMS, we tested it along with MDscan and 
MEME on four real ChIP-Seq datasets. The first three datasets, namely NRSF (neuron-
restrictive silencer factor) (4), STAT1 (signal transducer and activator of transcription 
protein 1) (68), and CTCF (CCCTC-binding factor) (67), are publically-available. The 
ER dataset, however, is newly generated for this study. The details of these four datasets 
can be found in Table A3.4A and appendix. 
3.3.2.1 Intra-motif dependency 
 It is well known that some positions of TF binding motifs exert an inter-
dependent effect on the binding affinities of TFs (87-90). However, due to the scarcity of 
the motifs identified for each TF, it is difficult to detect those dependent positions based 
solely on the limited motif sequence data. With the introduction of the ChIP-Seq 
technology, significantly more motif sequences can now be identified, which gives us 
unprecedented opportunity to identify dependent positions. Using the exhaustive search 
strategy we outlined in the methods section, we surveyed the four ChIP-Seq datasets used 




probability vectors— and  were presented 
in heatmaps (Figure 3.2 and Figure A3.3 in appendix). The two sets of probabilities of the 
16 dinucleotides were estimated under the independent and dependent models 
respectively. Larger distance indicated higher dependency. Using the Hamming distance 
of 0.2 as the threshold, the number of dependent position pairs in the motif ranged from 
three to five in the four real datasets we studied (Table A3.5 in appendix). These pairs 
formed two triplets in NRSF and CTCF motifs, one triplet and one pair in the STAT1 
motif and two triplets and one pair in the ER motif. In particular, we found that positions 
14 and 15 in the CTCF motif show exceptionally strong dependency. The frequency of 
dinucleotides AC and GG in these positions were below what would be expected if they 
were independent. Similarly, the frequency for dinucleotides AG and GC exceeded 
expectations. The probability of discrepancy between independent and dependent motif 
models exceeded 0.1 in all four relevant cells in the four by four table (Table A3.6 in 
appendix).  
 Although our search strategy considers all pairs equally, we found that the 
strongest intra-motif dependency occurred at pairs of adjacent positions (Figure 3.2 and 
Figure A3.3 in appendix). All 16 dependent position pairs we identified in the four motifs 
were adjacent. This is not surprising given the strong dependency in neighboring 
positions of DNA sequences. We also found that strong intra-motif dependency often 
occurred in the so-called ―gap‖ positions where the motif pattern appeared to be ―weak‖ 






Figure 3.2 Illustration of the unbiased exhaustive survey of all pairs of positions within 
the ER motif to assess the strength of their dependency. The differences in Hamming 
distance between the independent and dependent models are plotted in a heatmap. Larger 
differences (in dark red color) indicate higher dependency. Dependent triples: position 2, 
3 and 4, position 10, 11 and 12. Dependent pairs: position 18 and 19. Dependent 







3.3.2.2 TFBS motif profile comparison 
 Since both HMS and MDscan were able to rapidly process tens of thousands of 
DNA sequences without sacrificing much computation time, we fed the entire set of 
ChIP-enriched regions into these two programs. In this comparison, we only used the top 
500 sequences as input for MEME, since this program was not optimized to analyze large 
numbers of DNA sequences. Next, we applied MAST (96), a motif scanning software 
that is a companion to MEME, to scan the remaining sequences using the motif pattern 
identified by MEME. This is a commonly-used strategy in motif analysis (75). We also 
included motif patterns either from the literature (CTCF motif from Kim et al. (97)) or 
from MatBase (Genomatix, Software GmbH, Munich, Germany) for comparison. We 
used two different versions of HMS in our analysis: the default setting allowing 
dependency among positions in the motif and HMS_ind assumed all positions are 













Figure 3.3 Comparison of ER motif patterns identified by different de novo motif- finding 
tools, as well as known motif patterns stored in the MatBase (Genomatix Software 
GmBH, Munich, Germany). A. Logo plots (52) of motifs identified by various motif-
finding programs as well as the ones stored in the MatBase. The logo plots are generated 
using R package ―seqLogo‖ (53). B. Comparison of motif enrichment in ChIP-Seq using 
cross validation. C. Comparison of motif enrichment in ChIP-chip data using motif 
patterns identified in ChIP-Seq. In order to obtain a smooth curve when plotting 
empirical FDR versus Chi-square test statistics, we applied kernel smoothing using an R 
function smooth.spline(). 
A.  
Genomatix V$ER01:                                      Genomatix V$ER02: 
 
Genomatix V$ER03:                                     MEME: 
    
HMS: 
 






 Although the four TFs and their binding motifs were quite diverse, the motif 
pattern identification results were remarkably consistent. The results from the ER dataset 
are presented in Figure 3.3. Results from the three publicly available ChIP-Seq datasets 
can be found in Figure A3.4-A3.6 in appendix.  
 Figure 3.3A showed that de novo motif patterns identified by MEME and HMS 
from the ER ChIP-Seq dataset. Both patterns were similar to the ER motif stored in 
MatBase. However, the motif pattern identified by HMS was relatively less conserved 
(average information content: HMS: 0.64, MEME: 0.71, Genomatix V$ER01: 1.00, 
Genomatix V$ER02: 1.03, Genomatix V$ER03: 0.89) but more palindromic than the 
other motif patterns (Hamming distance between the two 6-mer half sites after one half 
site was converted to its reverse complement: HMS: 0.09, MEME: 2.57, Genomatix 
V$ER01: 4.00, Genomatix V$ER02: 2.18, Genomatix V$ER03: 2.53). We did not 
include MDscan in our comparison since MDscan was unable to consistently identify the 
consensus ER motif pattern. In Figure 3.3B, we plotted the Chi-square test statistics that 
measured the motif enrichment at different levels of the empirical FDR. Comparing 
AUC, we found that the motif patterns identified by MEME and HMS showed much 
higher AUC than the known motif patterns stored in MatBase. We believe that the 
dramatically increased number of binding sites identified by ChIP-Seq contributed to the 
refinement of the motif pattern. MEME and a simplified version of HMS (which used an 
independent mono-nucleotide model, referred as HMS_ind) exhibited a similar result. 
AUC for HMS, which allowed up to three-way interdependency, was 16.7% higher than 
MEME (Table A3.7 in appendix). The improvement is statistically significant when we 




MEME using a paired t-test (p-value < 0.00001). We also compared the proportions of 
ChIP-enriched sequences that contain each of the ER motif patterns shown in Figure 3A. 
We found that, under the two empirical FDR levels (0.05 and 0.1), the proportion of 
motif pattern defined by HMS is higher than that from HMS_ind (by 12.95% and 8.07% 
respectively). Comparing HMS to MEME under these empirical FDR levels, the 
proportion of motif pattern defined by HMS again is higher (by 19.52% and 9.20% 
respectively). These differences are again significant (p-value < 0.00001) when verifying 
with paired t-test comparing results from 100 cross-validations. In addition, we found that 
proportions of motifs reported by HMS, HMS_ind and MEME are much higher than 
those found in the MatBase (Table A3.8 in appendix). 
 Among the other datasets (NRSF, STAT1, and CTCF), HMS and MEME 
consistently identified the consensus motif patterns in all trials. MDscan was able to 
consistently identify only the NRSF motif, but not the ones for the other two datasets. 
Again, we found that the motif patterns identified by these de novo motif- finding tools 
were more enriched than known motif patterns found in the literature or MatBase. Motif 
patterns defined by HMS consistently showed higher enrichment and resulted in higher 
AUC than MEME (Figures A3.4-A3.6, Table A3.7 in appendix). Motif patterns defined 
by HMS are consistently found in more ChIP-enriched sequences than those defined by 
HMS_ind and MEME at the same empirical FDR levels (Table A3.8 in appendix). The 
performance differences are significant except for the STAT1 motif.  
3.3.2.3 Comparison to ChIP-chip data 
 In order to confirm that the higher enrichment of the motif identified by HMS on 




and control sequences using ChIP-chip. Not only the technology is different, but also the 
cells and antibodies used. Detailed information about these datasets can be found in Table 
A3.4B and appendix.  
 Despite all the differences, we found that the ER motif pattern identified by HMS 
from ChIP-Seq data once again exhibited significantly higher enrichment than those of 
HMS_ind and MEME (Figure 3.3C): the improvements of AUC were 17.5%, and 57.4%, 
respectively (Table A3.7 in appendix). These differences are statistical significant (p-
value < 0.00001). Similar plots and AUC comparisons performed on the other three 
datasets—NRSF, STAT1 and CTCF—showed comparable patterns (Figures A3.4-A3.6, 
Table A3.7 in appendix). These findings support that the motif pattern identified by HMS 
has a higher accuracy. 
3.3.3 Computation Time 
 All computation was performed on Dell PowerEdge 1950 compute nodes with 
2.83 GHz CPU processors and 8 GB RAM. To compare the computation time required 
for each algorithm, we selected the top 500, 1,000, 1,500, 2,000, up to 5,000 sequences 
identified from the NRSF ChIP-Seq data and fed them into the three motif- finding 
programs—MDscan, MEME, and HMS. We found MDscan to be the fastest, with HMS 
a close second. Computation time increased linearly with the number of sequences for 
MDscan and HMS; and both were much faster than MEME. The differences are quite 
dramatic. For real data, computation times for HMS ranged from 0.4 hours (NRSF data) 
to about 2.5 hours (CTCF data). However, since all parallel chains are independent, 




cluster. In contrast, MEME takes much longer; from 13 hours (NRSF data) to more than 
23 days (CTCF data, job aborted after 23 days of running).  
3.4 Discussion 
 The newly-emerged ChIP-Seq technology is capable of comprehensively 
revealing protein-DNA interacting sites across the entire genome with high resolution, 
which presents both opportunities and challenges for the identification of TFBS motif 
patterns. Increasing the number of input sequences allowed us to define TFBS motif 
patterns more accurately. However, most of the existing motif- finding programs such as 
MEME are not optimized to analyze the large number of input sequences that are 
generated from ChIP-Seq experiments. In this manuscript, we introduce HMS, a novel 
computational algorithm, specifically designed for TFBS motif discovery from ChIP-Seq 
data. It combines stochastic sampling with deterministic optimization in an iterative 
procedure. The assignment of sequences to these two treatments was dependent on the 
ranks of the ChIP-enrichment of those regions. This prioritized hybrid Monte Carlo 
strategy allows us to rapidly analyze tens of thousands of input sequences and produces 
an accurate estimate of the motif pattern. Our algorithm has the additional advantage of 
leveraging sequencing depth within each region to aid motif identification. Since the 
shape of sequencing depth is indicative of likely loci of the motif, using an informative 
prior gives HMS greater capability to identify weaker motifs than it could otherwise, a 
clear advancement. 
 In addition, using HMS we found that there is substantial intra-motif dependency 
among selected pairs of positions. We identified 16 highly significant position pairs 




to each other, some form triplets. In particular, we noticed a position pair (14 and 15) in 
the CTCF motif that displays exceptionally strong dependency in which dinucleotides 
AG and GC are far more frequent then AC and GG at these two positions. Using both 
simulated data and real data, we showed that incorporating dependent positions in a motif 
model offers further improvement in detecting and characterizing the underlying TF 
binding motif patterns.  
 Currently, most de novo motif searches on sequences identified by ChIP-Seq are 
conducted on a subset of all available sequences. This is because searching through the 
full set of thousands, or even tens of thousands, of input sequences using existing motif-
finding tools is extremely time-consuming. Our simulation study showed that this 
strategy, while convenient, has increased the likelihood of missing the true motif patterns. 
Further, the probability matrix  inferred with this strategy are often less accurate. In 
contrast, HMS allows us to analyze the full set of input sequences within only a fraction 
of the computational time required for existing de novo motif- finding tools like MEME. 
In this study, stochastic search was performed on the top 10% of all sequences. This 
proportion is adjustable by users. We have experimented increasing or decreasing the 
10% cutoff and found that these changes made little difference in the performance of 
HMS.  When applied to multiple real ChIP-Seq datasets, we found that the motif patterns 
identified by HMS tend to be more enriched than motifs identified by other methods.  
Remarkably, when comparing the same motif patterns identified from ChIP-Seq data to 
enriched regions identified from independent ChIP-chip experiments for the same TF, 
even with different cell types or different antibodies or both, we still found that motif 




relative to random control sequences. This finding suggests that the motif patterns 
identified by HMS are closer to the underlying motif pattern recognized by the TF.
 In this study, we utilized ChIP-enrichment of the peaks to rank order all input 
sequences, believing that ChIP-enrichment is positively correlated with the motif 
abundance. However, there are many potential reasons, both biological and technical, that 
a particular region is sequenced more deeply. These include the availability of the 
antibody’s epitope during the immunoprecipitation step, conformational changes on the 
TF, abnormality in the cell line such as aneuploidy, bias introduced during the 
sequencing library construction, nucleotide- induced sequencibility bias (such as GC 
content) and bias related to alignment (repeat regions, various polymorphisms). These 
complications will reduce the correlation between ChIP-enrichment and sequencing 
depth. We believe advanced models that consider these factors will further improve the 
performance of HMS. Another potential enhancement would be to model the protein-
DNA binding affinity indicated by read density using thermodynamic models (98).   
 In this study, if the motif width is unknown, we run HMS with every possible 
width within the range specified by the user and report all significant motif patterns. One 
possible improvement to this step would be to allow motif width  to vary during 
iterations (99). For example, we may add a Metropolis step, with equal probability of 
adding or removing one base at one end of the motif, and test whether the new motif 
pattern provides a better fit with the data. Another possible area for improvement 
concerns multiple binding sites. Currently, HMS is only designed to search for the 




However, we can also use HMS to identify secondary binding sites by masking the first 
motif identified and re-running HMS on the masked sequences. 
 In summary, we showed that ChIP-Seq data can significantly increase our ability 
to discover and refine TFBS motif patterns. However, new computational tools are 
needed in order to efficiently and thoroughly handle the ChIP-Seq data, as well as to 
exploit the various advantages of ChIP-Seq technology. The development of the highly 
scalable HMS algorithm represents an early attempt. With significant improvement in 
both accuracy and computation speed, we believe that HMS will be of broad interest to 
researchers conducting ChIP-Seq experiments and has the potential to accelerate 
discovery in biomedical research.   
3.5 Appendix 






















3.5.2 HPeak Software  
 HPeak (95) is a hidden Markov model (HMM)-based algorithm for analyzing 
ChIP-Seq data. The goal of HPeak is to partition the genome into segments that are either 
ChIP-enriched or non-enriched such that the enriched portion of the genome is much 
more likely to harbor protein-DNA interaction sites. The input data is a collection of 
sequencing reads that have been aligned to the reference genome uniquely. HPeak first 
partitions the entire genome into small bins of fixed length (e.g., 25 bps) and evaluates 
the distribution of ChIP DNA fragments in these bins throughout the genome. Next 
HPeak applies a two-state HMM on the sequencing depth profile to identify stretches of 
ChIP-enriched bins from the background. HPeak uses two different probability 
distributions, the generalized Poisson (GP) distribution (100) and the zero inflated 
Poisson (ZIP) distribution (101) to model the numbers of sequencing reads that overlap 
with ChIP-enriched and non-enriched bins respectively. Both these distributions are 
modified from the standard Poisson distribution to fit data where there is serious over or 




genome-wide sequencing read coverage profiles. Using a user-specified posterior 
probability threshold, HPeak then identifies stretches of bins from the HMM that show 
significant enrichment of sequencing read counts. Each set of bins is defined as a peak. In 
addition to its genomic location and the length of the peak, HPeak also reports the 
location of the highest sequencing depth within the peak, the actual maximum sequencing 
depth at that location, and the posterior probability of these bins be ing ChIP-enriched. 
Because such probability reflects the significance of these peaks, one can rank all peaks 
predicted by HPeak using these probabilities. HPeak software is freely available from the 
website http://www.sph.umich.edu/csg/qin/HPeak/. 
3.5.3 Estrogen Receptor ChIP-Seq Experiment on MCF7 Cells 
 MCF-7 cells were grown in RPMI media supplemented with 10% FBS to 50% 
confluence. The cells were then hormone-starved for three days prior to the treatment 
with 10 nM β-estradiol or vehicle control for 45 minutes. The cells were then harvested 
for ChIP analysis as previously described using an antibody against the estrogen receptor 
(ER)-alpha (sc-543x, Santa Cruz Biotechnology Inc, Santa Cruz, CA) or the IgG control. 
Briefly, cultured cells near 90% confluence were crosslinked with 1% formaldehyde for 
10 minutes and the crosslinking was inactivated by 0.125 M glycine for 5 minutes at 
room temperature (RT). The cells were then rinsed with cold 1X PBS twice and scraped 
off in 1X PBS + protease inhibitor (PI). Cells were pelleted and resuspended in cell lysis 
buffer plus PI for 10 minutes. Nuclei pellets were spun at 5,000 rpm for 5 minutes, 
resuspended in nuclear lysis buffer, and then incubated for 10 minutes. Chromatin was 
sonicated to an average length of 500 bp with an Ultrasonic Processor Sonicator 3000 




remove the debris. Supernatants containing chromatin fragments were incubated with 
agarose/protein A or G beads (Millipore. Billerica, MA) for 15 minutes and centrifuged 
at 5,000 rpm for 5 minutes to remove the nonspecific binding. To immunoprecipitate 
protein/chromatin complexes, the supernatants were incubated with 3-5 µg of antibody or 
IgG overnight, then added 50 µl of agarose/protein A or G beads and incubated for 
another hour. Beads were washed twice with 1X dialysis buffer and four times with IP 
buffer. The antibody/protein/DNA complexes were eluted with 150 µL IP elution buffer 
twice. To reverse the crosslinks, the complexes were incubated in elution buffer plus 10 
µg RNase A and 0.3 M NaCl at 67 C for four hours. DNA/proteins were precipitated 
with ethanol, air-dried, and dissolved in 100 µL of TE. Proteins were then digested by 
proteinase K at 45 C for one hour and DNA was purified with a QIAGEN PCR 
purification column and eluted with 30 µL EB buffer.  
 The ChIP-enriched DNA was evaluated for significant enrichment of positive 
control genes and then subjected to ChIP-Seq sample preparation following the 
manufacturer’s protocols (Illumina Inc, San Diego, CA). Briefly, the ends of ChIP-
enriched DNA or control DNA (~10 ng) was first repaired by T4 DNA polymerase, T4 
PNK, and Klenow DNA polymerase at 20 C for 30 minutes. An ―A‖ base was added to 
the 3’ end of the blunt phosphorylated DNA fragments using Klenow exo at 37 C for 30 
minutes. Adapters were then ligated to the ends of the DNA fragments by DNA ligase at 
RT for 15 minutes. DNA fragments were separated on 2% gel at 100V for 1 hour, the 
200 25bp band was excised from the gel, and the DNA was extracted by QIAGEN gel 
extraction kit. Gel-extracted DNA was amplified by PCR reaction for 16 cycles and 




Sequencing was performed using the Illumina Genome Analyzer according to standard 
manufacturer’s procedures. The raw sequencing image data were analyzed by the 
Illumina analysis pipeline, aligned to the unmasked human reference genome (NCBI v36, 
hg18) using Eland software (Illumina Inc, San Diego, CA) to generate sequence reads of 
35 bps. 
3.5.4 Simulation scheme for studying intra-motif dependency 
 As described in the Methods section of this chapter, for a pair of positions within 
the motif, we use the Hamming distance between two sets of estimated dinucleotide 
frequencies based on two competing probability models (16-component multinomial 
distribution or the product of two four-component multinomial distributions) to gauge 
whether the two positions are dependent. To select a reasonable cutoff, we conducted a 
simulation study to estimate the null distribution for such Hamming distances. We 
considered five levels of nucleotide conservation, with information content ranging from 
0.29 to 1.76 (0.29, 0.64, 1.15, 1.42 and 1.76). There are in total 15 different combinations 
of these information contents. For each combination, we specify two four-component 
multinomial distributions that match the two information content levels. One thousand 
nucleotides were drawn from each of the two multinomial distributions independently. 
We choose the large number to reflect the fact that typically large amounts of motifs were 
identified from ChIP-Seq experiments. The Hamming distances were calculated using 
formula (3.4) in this chapter: 






We simulated one million position pairs using the above procedure in order to obtain an 
accurate null distribution of the background Hamming distance. The histograms of these 
Hamming distances were shown in Figure A3.7. From these plots we found that strong 
dependency (large Hamming distance) tends to occur between a pair of positions in 
which each position itself is weakly conserved.  
3.5.5 Tables in appendix 
Table A3.1A Four motif models for two motif widths and two motif strengths used in the 
simulation study. 
 
Motif Consensus (Width) Motif information content 
S1 (high) S2 (low) 
GACTACCA (W8) 1.42 0.93 
AGGATCTAATGATCCT (W16) 1.42 0.93 
 
Table A3.1B Two motif abundances scheme used in the simulation study.  
 
Expected copies of motif segments Motif abundance 
A1 (high) A2 (low) 
Top 25% sequences 0.9 0.6 
25% - 50% sequences 0.7 0.4 
50% - 75% sequences 0.5 0.2 
Last 25% sequences 0.3 0 










Table A3.2A Performance comparison on simulated data assuming all positions within the motif are independent.  
 
Simulation Times_found2  Difference compared to HMS3 
setting1  HMS HMS_uniform MEME MDscan HMS_uniform MEME MDscan 
W8S1A1 100 100 100 100 0.01** 0 0.11**  
W8S1A2 100 100 100 100 0.00** 0 0.09**  
W8S2A1 100 100 71 33 0 0.07**  0.11**  
W8S2A2 100 100 78 96 0.01 0.09**  0.02 
W16S1A1 100 100 100 100 0 0.02**  0.12**  
W16S1A2 100 100 100 100 0.00**  0.02**  0.10**  
W16S2A1 100 100 100 54 0.00*  0.02**  0.21**  














Table A3.2B Performance comparison on simulated data assuming some positions within the motif are dependent. 
 
Simulation Times_found2  Difference compared to HMS3 
setting1  HMS HMS_uniform MEME MDscan HMS_uniform MEME MDscan 
W8S1A1 98 98 63 96 0 0.10**  0.11**  
W8S1A2 100 100 85 93 0 0.09**  0.10** 
W8S2A1 92 89 0 2 -0.01#  NA 0.09#  
W8S2A2 73 69 0 61 0.03 NA 0.09**  
W16S1A1 100 100 100 100 0 0.22**  0.28**  
W16S1A2 100 100 100 100 0 0.21**  0.26**  
W16S2A1 100 100 100 40 0 0.21**  0.31**  













 1Each simulation setting is a combination of motif width (W), information content (S) and motif abundance (A). The scheme is 
similar to Liu et al, (2001) (54) and described in Table A3.1.  
2―Times found‖ indicates among the 100 simulated dataset, how many times the correct motif is identified by the motif- finding 
algorithm.  
3Difference referrers to the difference between two average Hamming distances h and hHMS in which h measures average discrepancy 
(per base) between probability matrix  and its prediction denoted as  (Formula (3.11)). hHMS measures 
average discrepancy (per base) between probability matrix  and  predicted by HMS method. We use * to indicate a p-value in 
paired t-test between 0.01 and 0.05 and ** to indicate a p-value in paired t-test less than 0.01. # indicates that p-value is not available 
















Table A3.3 The joint distribution of dinucleotides in two dependent positions. The probabilities in this multinomial distribution are 
taken from the one predicted for position pair (1,2) in the E2F motif in Zhou and Liu (93) (Figure 2(b) in their paper). 
First Base Second Base 
A C G T 
A 0 0 0.19 0 
C 0 0 0.16 0.06 
G 0 0.09 0 0 
T 0 0.44 0.06 0 
  
Table A3.4A Information on the four real ChIP-Seq datasets 
TF Cell type Antibody # of peaks Coverage Reference 
NRSF Jurkat T cell Monoclonal antibody 12C11 4,982 1.4 MB Johnson et al. (2007) 
STAT1 HeLa S3 cell Rabbit polyclonal antibody  27,470 8.1 MB Robertson et al. (2007) 
CTCF CD4+ T cell Upstate 07-729 22,159 7.4 MB Barski et al. (2007) 
ER MCF7 cell ER α (HC-20) 10,072 2.5 MB Hu et al. (2010) 
 
Table A3.4B Information on the four real ChIP-chip datasets  
TF Cell type Antibody # of peaks Coverage Reference 
NRSF Jurkat T cell Monoclonal antibody 8,819 12.2 MB Johnson et al. (2007) 
STAT1 HeLa S3 cell α p91 (C-24) rabbit polyclonal antibody 3,701 4.7 MB Euskirchen et al. (2007) 
CTCF IMR90 and U937 cell Mixture of 9 monoclonal antibodies 13,804 12.1 MB Kim et al. (2005) 






Table A3.5. Dependent positions identified in four motifs from ChIP-Seq data. 
 
Motif Top dependent pairs Hamming distance 
NRSF width = 21 bp (18-19) 0.3308  
Dependent positions: (3-4) 0.3297  
[(2-3)(3-4)] [(18-19)(19-20)] (19-20) 0.3196  
  (2-3) 0.2629  
CTCF width = 24 bp (14-15) 0.4635  
Dependent positions:  (16-17) 0.3358  
[(13-14)(14-15)] [(16-17)(17-18)] (17-18) 0.2720  
  (13-14) 0.2664  
STAT11 width = 19 bp (7-8) 0.3052  
Dependent positions:  (6-7) 0.2853  
[(6-7)(7-8)] (13-14) (13-14) 0.2008  
ER width = 19 bp (11-12) 0.2562  
Dependent positions:  (10-11) 0.2553  
[(2-3)(3-4)] [(10-11)(11-12)] (18-19) (18-19) 0.2327  
 
(3-4) 0.2260  








Table A3.6. The probability mass function of 16-component multinomial distribution (dependent) of position 14 and position 15 in the 
CTCF motif, and the probability mass function of 16-component multinomial distribution (independent) of position 14 and position 15 
in CTCF motif (the outer product of the probability mass function of  two independent four-component multinomial distributions).  
 
 
Position 15 Marginal 
distribution Position 14 A C G T 
A 0.03 (0.04) 0.14 (0.25) 0.28 (0.16) 0.03 (0.03) 0.48 
C 0.00 (0.00) 0.01 (0.01) 0.00 (0.00) 0.00 (0.00) 0.01 
G 0.05 (0.04) 0.34 (0.24) 0.06 (0.17) 0.03 (0.03) 0.48 
T 0.00 (0.00) 0.02 (0.01) 0.00 (0.01) 0.00 (0.00) 0.02 












Table A3.7. Comparison of motif enrichment among motif patterns identified by different de novo motif finding tools as well as 
known motif patterns described in the literature or stored in the MatBase (Genomatix Software GmBH, Munich, Germany). 
Area under the curve1 ChIP-Seq
2 ChIP-chip3 
NRSF STAT1 CTCF ER NRSF STAT1 CTCF ER 
HMS 258.62** 439.68 2312.87** 327.99** 163.08** 94.23** 1102.02** 1216.94** 
HMS_ind 254.73** 388.99 2198.81** 290.30 161.98** 83.75 1001.35** 1035.42** 
MEME 242.83 440.33 2076.76 281.14 148.76 82.95 908.35 773.30 
MDscan 240.16 -- -- -- 143.25 -- -- -- 
Genomatix V$NRSF 210.38 -- -- -- 36.38 -- -- -- 
Genomatix V$STAT01 -- 77.39 -- -- -- 9.69 -- -- 
Genomatix V$STAT03 -- 191.70 -- -- -- 28.96 -- -- 
Kim07_CTCF -- -- 1225.97 -- -- -- 509.62 -- 
Genomatix V$ER01 -- -- -- 35.29 -- -- -- 292.43 
Genomatix V$ER02 -- -- -- 35.05 -- -- -- 71.48 
Genomatix V$ER03 -- -- -- 87.40 -- -- -- 245.37 
1Area under the curve (AUC) in the empirical FDR versus Chi-square test statistics plot (Figure 3.3B and C, Figures A3.4-A3.6 B and 
C). Values in bold indicate the best performance in that column. Five cross-validations were performed on each dataset using each of 
the four motif finding algorithms. In addition, we conducted cross-validation 100 times and compared the AUCs obtained from two 
different method using a paired t-test to assess whether the performance difference we observed in statistical significant. We use ** 
indicates an empirical p-value less than 0.01. 
2The empirical FDRs for NRSF, STAT1, CTCF and ER ChIP-Seq data sets all range from 0 to 0.2. 
3The empirical FDRs for NRSF and CTCF ChIP-chip data sets range from 0 to 0.2. The empirical FDRs for STAT1 and ER ChIP-chip 




Table A3.8. Comparison of motif enrichment among the three motif finding tools and 
known motif patterns stored in the MatBase (Genomatix GmBH, Munich, Germany).1  
 
ChIP-Seq NRSF STAT1 CTCF ER 
Empirical FDR2  0.05 0.1 0.05 0.1 0.05 0.1 0.05 0.1 
HMS 49.30 51.41 10.84 25.29 79.05 84.45 29.39 38.57 
HMS_ind 48.25 51.09 10.12 22.10 75.91 83.10 26.02 35.69 
MEME 46.63 49.55 10.28 24.08 72.43 81.16 24.59 35.32 
MDscan 45.21 49.11 -- -- -- -- -- -- 
Genomatix V$NRSF 41.09 42.52 -- -- -- -- -- -- 
Genmoatix V$STAT01 -- -- -- -- -- -- -- -- 
Genomatix V$STAT03 -- -- 10.09 12.16 -- -- -- -- 
Kim07_CTCF -- -- -- -- 56.68 62.01 -- -- 
Genomatix V$ER01 -- -- -- -- -- -- -- -- 
Genomatix V$ER02 -- -- -- -- -- -- -- -- 
Genomatix V$ER03 -- -- -- -- -- -- 10.62 14.56 
 
1Values in the table are percentages of ChIP-enriched sequences that contain the specific 
motif pattern. Values in bold indicate the best performance in that column.  
2The empirical FDR is estimated by dividing the number of control sequences that 













3.5.6 Figures in appendix 
Figure A3.1 Rank order of all ChIP-enriched regions versus location of motifs. Zero in 
the y-axis indicates the location of highest sequencing depth in the ChIP-enriched regions 
obtained from HPeak program. For each position  within a ChIP-enriched region 
, we calculate a motif score defined as equation (3.1), measuring the similarity between 
the DNA sequence of length w (motif length, assumed known) starts from the current 
location and the known motif pattern represented by PSWM. Higher scores indicates 
better match. We record the position with highest motif score for each ChIP-enriched 
region . For each dot, the x-axis represents the rank of ChIP-enriched region (from the 
highest to the lowest), and the y-axis represents the physical position of the most likely 
motif location in each ChIP-enriched region. The red dots indicate the motifs with score 
above the first quantile, and the yellow dots indicate the motifs with score between the 
first quantile and median. A. NRSF, B. STAT1, C. CTCF, D. ER. 













C.                 D. 
 
 
Figure A3.2 Illustration of the informative prior distribution of motif start locations. The 
prior probabilities (solid black line) are proportional to a discretized Student’s t 
distribution with three degrees of freedom (with standard error = 1.73) and rescaled such 
that the prior probabilities form a step function with a fixed step-size (25 bp in this study). 
The solid red line represents the probability density function of shifted and rescaled 





Figure A3.3 Illustration of the unbiased exhaustive survey of all pairs of positions within 
the motif.  Larger differences (in darker color) indicate higher dependency.  
 
NRSF: (2,3,4) (18,19,20)                                        
  
CTCF: (13,14,15) (16,17,18) 
  
  











Figure A3.4 Comparison of NRSF motif patterns identified by different de novo motif 
finding tools as well as the  known NRSF motif found in the MatBase (Genomatix 
Software GmBH, Munich, Germany). A. Logo plots of motifs identified by various motif 
finding programs as well as the NRSF motif stored in the MatBase. B. Comparison of 
motif enrichment in ChIP-Seq using cross validation. C. Comparison of motif enrichment 
in ChIP-chip data using motif patterns identified in ChIP-Seq.  
A. 
Genomatix:                                                                    MEME: 
 
MDscan:                                                                        HMS: 
 







Figure A3.5 Comparison of STAT1 motif patterns identified by different de novo motif 
finding tools as well as known STAT motif patterns stored in the MatBase (Genomatix 
Software GmBH, Munich, Germany). A. Logo plots of motifs identified by various motif 
finding programs as well as the STAT motifs stored in the MatBase. B. Comparison of 
motif enrichment in ChIP-Seq using cross validation. C. Comparison of motif enrichment 
in ChIP-chip data using motif patterns identified in ChIP-Seq. Note: the x axis in STAT1 
ChIP-chip figure is from 0 to 1.0 instead of the usual range of 0 to 0.2 due to its high 
empirical FDR.  
A. 
Genomatix V$STAT01:                                       Genomatix V$STAT03: 
 
MEME:                                                                  HMS: 
 








Figure A3.6 Comparison of CTCF motif patterns identified by different de novo motif 
finding tools as well as a known motif pattern found in Kim et al. (2007). A. Logo plots 
of motifs identified by various motif finding programs as well as the one found in Kim et 
al. (2007). B. Comparison of motif enrichment in ChIP-Seq using cross validation. C. 
Comparison of motif enrichment in ChIP-chip data using motif patterns identified in 
ChIP-Seq.  
A. 















Figure A3.7 The histogram of 15 empirical distributions of Hamming distance. The label 
 shown under each of the 15 empirical distributions of Hamming 
distance indicates the 15 combinations of information content. Small ,  represent low 
information content, while large ,  represent high information content.  
 
     
 
    
  
   
   
  









CHAPTER 4  
 





 The transcriptome is the complete set of transcripts in a cell under any given 
developmental stage or physiological condition. Comprehensively cataloging all the 
components in the transcriptome is a grand challenge in the post-genome era. In the past 
decade, microarray technology has played a prominent role in advancing our 
understanding of transcriptome complexity. Microarray is a hybridization-based 
technology that incubates fluorescently- labeled cDNA with custom-made microarray or 
commercial GeneChips. Microarray allows scientists to simultaneously monitor the 
expression of almost all the genes in the genome, and along with a steady reduction in 
processing costs, led to its wide spread application. Despite its overwhelming success, 
microarray technology has its limitations. First, design probes on the microarray requires 
knowledge of the genome sequence, hence novel transcripts will be missed. In addition, 





 Sequencing-based approaches to measure gene expression have the potential to 
overcome these limitations. The ultra-high-throughput next generation sequencing (also 
known as massively parallel sequencing) technologies capable of producing millions of 
sequence reads are making the transition from development to widespread application 
rapidly. These technologies are able to dramatically increase the throughput in DNA 
sequencing compared to conventional Sanger technology and at much lower cost. An 
array of studies have been published that successfully apply these new sequencing 
technologies to measure mRNA expression levels on cells from various species including 
Saccharomyces cerevisias, Schizosaccharomyces pombe, Arabidopsis thaliana, mouse 
and human cells (102-108). In RNA-Seq experiments, a population of RNA is converted 
to a library of cDNA fragments with adaptors attached to one end. Each molecule, after 
amplification, is then sequenced using one of the next generation sequencing 
technologies. Following sequencing, the resulting reads are aligned to either the reference 
genome or known transcripts to produce a genome-scale transcriptional profile.   
 While sequencing costs have significantly declined with the advent of the new 
technologies, the amount of data the new platforms produce is skyrocketing, thereby 
producing an analytical bottleneck. To match the advancement provided by the new 
sequencing technologies, significant attention and effort needs to be directed to the 
statistics and bioinformatics front. Sophisticated and tailor-made data analysis strategies 
are needed in order to fully realizing the power of the new sequencing technologies.  
 In order to quantify and compare transcriptions between different genes or 
between different experiments, read data generated by RNA-Seq needs to be properly 




literature. Mortazavi et al. (2008) (104) proposed measuring the transcript levels in reads 
per kilobase of exon per million mapped reads (RPKM), which takes into consideration 
RNA length and the total read number in the measurement. The RPKM measure is 
essentially an averaging estimate of the transcript's expression intensity assuming an 
underlying Poisson or binomial model. Similar approaches have been used by other 
authors, for example, Bullard et al. (2009) (109) and Marioni et al. (2009) (107). All 
these methods utilize reads data at either the gene level or at the exon level. The counts of 
the bases demonstrate fairly large base-specific variations and between-base correlations 
(see preliminary analysis of a real RNA-Seq dataset in appendix), which we believe are 
attributed partly to the RNA-Seq technology and partly to some transcription 
mechanisms. Most current methods, including the RPKM measure and the method 
proposed by Jiang and Wong (2010) (110), do not take into consideration the base- level 
variations and correlations. As a result, the estimation of transcript expression will 
become less efficient, especially for low-expressed isoforms. In addition, it will 
compromise the comparison of transcript expressions between genes or between different 
experiments and hinder the discovery of novel transcript activities.  
 Because between-base correlations depend on the relative distances between 
bases, they are referred to as one-dimensional spatial correlations or in short spatial 
correlations in this study. The presence of location-specific variations along with spatial 
correlation is a characteristic of many spatial data sets generated in geostatistics, spatial 
epidemiology, and image processing and has been studied in the literature of spatial 
statistics. In this study, we apply and extend the ideas, models, and methodologies rooted 




4.2 Methods  
4.2.1 Spatial Poisson regression model 
 We consider RNA-Seq data at the single exon level in this study. Observed 
sequencing depth often demonstrates substantial variation and spatial correlation (see 
preliminary analysis of a real RNA-Seq dataset in appendix), which is attributable to both 
biological and technological factors. As a consequence, simple summary statistics 
measures such as the total number of reads within the exon boundary will be adversely 
affected by these complications. To overcome these problems, we propose to model the 
sequencing depth at each base accounting for the spatial correlation. These models 
explicitly take into consideration the variation and the correlation; therefore they are 
capable of facilitating proper normalization on sequencing depth at the base- level. 
 Let  represent the sequencing depth at the  th base of the specified exon in the 
 th sample in a study. Here  and  is the length of the exon; , and 
 is the total number of replicated samples. Our goal is to build a probability model, 
analogous to the one proposed in Li and Wong (2001) (111) for modeling the probe- level 
microarray data, to capture the observed variation in . There are many factors, both 
biological and technological, that affect . In order to keep the model simple and to 
avoid overfitting, we propose to use spatial Poisson regression models.  
 At least five different categories of factors contribute to the variation of the reads 
. The most important category, also the one we are most interested in estimating, 
consists of the biological factors that represent the expression level of this exon in the cell 




Suppose there are in total  such biological factors in the  th sample, denoted by 
. Let . 
 The second category represents factors that are specific to the current sample. 
They arose from the sample preparation step and sequencing process, hence are referred 
to as technical factors. An example is the lane effect. Compared to other factors, studies 
have shown that variation introduced by technical factors is typically not significant 
(107). Suppose there are in total  such technical factors in the  th sample, denoted by 
. Let . 
 The third category includes systematic biases introduced by intrinsic local 
genomic features, such as GC content that affect sequencing depth. This type of bias is 
platform-specific. As an example, Dohm et al. (2008) (112) showed that the sequencing 
depth is positively correlated with GC content using the Illumina/Solexa platform. We 
use a generic term  to represent biases that belong to this category. In the preliminary 
analysis of a real RNA-Seq dataset (appendix), we observed a quadratic association 
pattern between sequencing depth and GC content. Therefore we add both first and 
second order terms of GC content in the model.  
 The factors in the first three categories are considered fixed. The last two 
categories contain random effects. The fourth category consists  of random effects 
 at base  through  in the  th sample, respectively. As in 
spatial statistics, ’s are assumed to be independent and identically distributed as 
. These effects are used to account for unstructured variability, which may be 




 The last category includes  representing the spatial 
correlation between the base counts. Like in spatial statistics, there are many ways to 
specify this spatial correlation structure. In this study, we will primarily investigate two 
configurations, the joint structure and the conditional or ICAR structure. 
 One way to specify the spatial correlation structure of ’s in the  th sample is 
to assume that they follow the same multivariate Gaussian distribution , where 
 is the correlation matrix of ’s and . It is usually not 
possible to estimate a general covariance matrix . Often,  is assumed to be a 
parametric function of distance  between the  th base and the  th base. Clearly, the 
parametric function cannot be arbitrary and is required to result in a positive definite 
matrix . One popular choice is  where  is a parameter determining the extent 
of correlation. This structure is referred to as the joint structure.  
 Another approach is to impose the correlation structure locally using a Gaussian 
Markov random field. This idea was originally proposed by Besag (1974) (113) and 
others, and was used by both Clayton and Kaldor (1987) (114) and Besag et al. (1991) 
(115). For a fixed base , first we need to define its neighborhood . A simple approach 
is to define  as the collection of every base  which is adjacent to base . Other 
definitions are possible, for example, Cressie and Chan (1989) (116) defines 
neighborhoods in terms of the distance . Second, we need to define a weight matrix 
 as follows. For ;  if ; and  
otherwise. Let  denote the collection of ’s with . The conditional 




  (4.1) 
The correlation is referred to as the Gaussian Markov structure or the intrinsic conditional 
autoregressive (ICAR) structure.  
 The discussion about the pros and cons of the joint and ICAR structures can be 
found in Best el al. (2005) (117) and Wakefield (2007) (118). Other more sophisticated 
models are also available in the literature. Two examples are the mixture model proposed 
by Green and Richardson (2002) (119) and the spatial partition model proposed by 
Knorr-Held and Raber (2000) (120). Best et al. (2005) (117) presents a thorough 
simulation study for comparing the performances of different models, and concludes that 
both the joint and ICAR structures have good properties for disease mapping. Covariates 
and deterministic spatial trends can be incorporated into the two structures in a 
straightforward fashion. 
 In the literature on disease mapping, MCMC methods are the predominant 
methods used for model fitting and inference, following Besag et al. (1991) (115) and 
Diggle et al. (1998) (121). In the literature on imaging processing, however, maximum 
likelihood methods are also used; see Zhu et al. (2009) (122) for example. The preference 
for Bayesian computational methods is due to the fact that the spatial random effects 
’s and ’s are not directly observable; and it takes high-dimensional integration to 
integrate them out, which can be computationally challenging. In the study, we will 
follow the tradition of using Bayesian computational methods when we apply the spatial 




 We propose the following spatial Poisson regression model for RNA-Seq data of 




Where , , ,  and  are the model parameters. In 
addition, the specifications of the random effects also include more parameters, 
depending on which configuration is adopted.  
 When the joint structure is assumed for ’s, then the model specified by (4.2) is 
referred to as the joint spatial Poisson regression model; when the ICAR structure is 
assumed for ’s, then the model specified by (4.2) is referred to as the ICAR spatial 
Poisson regression model. Note that the weight matrix  has to be further specified 
when we use ICAR structure for ’s. In this study, we define the neighborhood  as 
the adjacent bases. If we not only include the bases directly adjacent to  but also include 
bases that are within  bases of , assigning equal weights to bases in  may be not 
appropriate, therefore other weighting schemes need to be considered.  
 The expression level of the exon in the  th sample under biological factor  can 
be defined as , which is adjusted by GC content bias term , the technical 
factor , the location-specific random effect  and the spatial random effect . From 
the model the term  can be used as the normalized expression level for 
comparison between different exons and between different cell lines.  
4.2.2 Model implementation 
 We adopt a Bayesian approach and use MCMC methods to carry out estimation 




marginal distribution of random effects  and  are  and , 
respectively. If we specify inverse Gamma priors for  and , then the implied prior 
for  is not inverse Gamma so that we cannot easily control the total variance. 
Following the notations in Wakefield (2007) (118), we write the total precision as: 
, and specify a Gamma prior . Then let  
represent the proportion of the total variation that is attributable to the spatial component, 
and assign a Beta prior, , to , and transform from  to  via: 
  (4.3) 
 If the joint structure is assumed for ’s, there is another parameter  
determining the extent of global correlation. We assign another Beta prior, , to 
. We assign non- informative prior  for , and ,  for  
and .  
 In the default setting, we set uniform priors for  and  with . 
In addition, we use weakly informative priors for  and  with , 
. It is tricky to assign a prior for the total precision . We use an 
empirical Bayesian method: use moment estimate  to assign an informative prior  
for . Specifically, we consider a simplified joint spatial Poisson regression model with 
no biological factors, technological factors or systematic biases.   
  (4.4) 
The marginal distribution of random effects  and  are  and , 
respectively.  and  are independent. It is straightforward to calculate the first 










Then we can get the moment estimate  for total precision :  
  (4.7) 
where 
  (4.8) 
 To avoid taking the logarithm of a negative number, we only work on exons with 
 (see over-dispersion filter in real data analysis section). We fix the 
coefficient of variation (CV: ratio of the standard deviation to the mean) to be 1 in the 
informative prior  for  by setting and . 
 It is straightforward to derive the joint posterior distribution (formulas in 
appendix), and we use Gibbs sampler to iteratively sample parameters from the 
conditional posterior distribution. Since we use conjugate priors, the conditional posterior 
distributions for  and  are Gamma distributions, which are easy to sample. The 
conditional posterior distributions for fixed effects  and , and random effects ’s and 
’s are complicated and not in closed forms. Fortunately, they are all log-concave 
functions, and we can use adaptive rejection sample (ARS) (123) to draw samples. For 
the other parameters,  and , their conditional posterior distributions are not log-




sampling (ARMS) (124) to draw samples from these complicated distributions. One 
important issue in using ARS and ARMS is to assign appropriate ranges for the 
parameters. In ARS, we use interval  for fixed effects  and , and interval 
 for random effects ’s and ’s, respectively. In ARMS, we use the natural 
boundary  for the parameters,  and . 
 In addition, to make the intercept term ’s identifiable, we add two constraints 
on the random effects in each iteration of the Gibbs sampler: 
  (4.9) 
To be specific, at the end of each iteration, we replaced  and by  and 
. 
4.3 Simulation study 
 In this study, we propose the spatial Poisson regression model for exon level 
RNA-Seq data. This model is able to capture spatial correlation and non-spatial variation, 
and we believe the expression index estimated from such model will reflect the 
underlying expression levels more accurately. The reads per kilobase of exon per million 
mapped reads (RPKM) proposed by Mortazavi et al. (2008) (104) is one of the most 
popular existing methods to measure exon level gene expression. RPKM takes into 
consideration exon length and the total read number in the measurement, and it can be 
calculated as the normalized sample mean. Another similar approach is to use the 
normalized sample median (the median number of reads within an exon per kilobase of 
exon model per million mapped reads), which is robust to sporadic outliers. Next we 




measurement estimated by the spatial Poisson regression models, the normalized sample 
mean method and the normalized sample median method.  
 To make the simulation study simple and still without loss of generality, we did 
not consider the technical factors. Further we only incorporated one biological factor: 
cases vs. controls. We assumed that the cases and the controls are independent and have  
distinct parameters; therefore we can simulate them independently.  
4.3.1 No systematic bias 
 We started from a simple case with no systematic bias. Let  represent the 
sequencing depth at the  th base of a specified exon where , and  is 
the length of the exon; , and  is the number of duplicated samples. 
Here  is an index for the experimental conditions:  indicates the case sample, and 
 indicates the control sample. We simulated the seven cases and the seven controls 






 We need to specify parameters: , , , , ,  and  in the 
simulation. First assuming that expression levels in the cases and the controls were the 
same , and then the true fold change was .  was set to  
since the real RNA-Seq data exhibited strong spatial correlations (see preliminary 
analysis of a real RNA-Seq dataset in appendix). To mimic distinct variability observed 
in the real RNA-Seq data (Figure A4.1 in appendix), we designed five combinations of 








Spatial Non-spatial Spatial Non-spatial 
variance  variance variance  variance 
A 0.04 0.01 0.04 0.01 
B 0.05 0.02 0.04 0.01 
C 0.04 0.01 0.05 0.02 
D 0.05 0.01 0.04 0.02 
E 0.04 0.02 0.05 0.01 
  
 In setting A, the total variances of two random effects are the same in the cases 
and the controls, and the ratios between spatial and non-spatial variances are the same too. 
In setting B, the total variance of two random effects in the cases is larger than that in the 
controls. In setting C, the total variance of two random effects in the cases is smaller than 
that in the controls. In setting D, the total variances of two random effects are the same in 
the cases and the controls, but the ratio between spatial and non-spatial variances in the 
cases is larger than that in the controls. In setting E, the total variances of two random 
effects are the same in the cases and the controls, but the ratio between spatial and non-
spatial variances in the cases is smaller than that in the controls.  
 We estimated expression indexes for the cases and the controls, and the 
corresponding fold change (ratio) using four methods: the joint spatial Poisson model, the 
ICAR spatial Poisson model, the normalized sample mean method and the normalized 
sample median method. For two spatial Poisson models we proposed, we used 10,000 
iterations in each Gibbs sample. The first 9,000 samplers were dropped as the burn- in 
stage, and then every 10th sample in the last 1,000 samples were used to calculate the 




We repeated 100 simulations for each of five cases, and recorded the mean estimate and 
the mean square error (MSE) across 100 simulations (Table 4.2). 
 
Table 4.2 Simulation results when there is no systemic bias. Best methods (smallest MSE) 
in each setting are listed in bold font.  
 
Settings Methods 
Case Control Fold change 
Estimate MSE Estimate MSE Estimate MSE 
A 
Joint 1.000354 0.000014 0.999733 0.000019 1.000642 0.000036 
ICAR 1.000749 0.000015 0.999944 0.000019 1.000826 0.000037 
mean 1.022173 0.000514 1.021895 0.000508 1.000302 0.000052 
median 0.999950 0.000070 0.998843 0.000066 1.001178 0.000147 
B 
Joint 1.000660 0.000015 1.000020 0.000016 1.000656 0.000032 
ICAR 1.000379 0.000015 1.000253 0.000016 1.000143 0.000032 
mean 1.031257 0.001004 1.021648 0.000493 1.009431 0.000142 
median 0.999607 0.000080 1.000014 0.000081 0.999686 0.000187 
C 
Joint 1.000329 0.000015 1.000202 0.000013 1.000139 0.000026 
ICAR 1.000540 0.000015 0.999944 0.000013 1.000609 0.000026 
mean 1.022173 0.000513 1.030123 0.000929 0.992300 0.000094 
median 0.999771 0.000072 0.999457 0.000080 1.000398 0.000158 
D 
Joint 1.000503 0.000015 1.000829 0.000014 0.999688 0.000029 
ICAR 1.000698 0.000016 1.000083 0.000014 1.000630 0.000031 
mean 1.026408 0.000721 1.027008 0.000754 0.999441 0.000047 
median 1.000614 0.000071 1.000464 0.000085 1.000255 0.000195 
E 
Joint 1.000507 0.000016 1.000225 0.000015 1.000296 0.000030 
ICAR 1.000003 0.000017 1.000498 0.000014 0.999519 0.000032 
mean 1.027096 0.000762 1.026273 0.000717 1.000830 0.000056 
median 0.999164 0.000069 1.000129 0.000095 0.999139 0.000182 
 
 As we expected from a simple calculation (appendix), the normalized sample 
mean method overestimated the expression level of the cases and the controls (1.0216 ~ 




provided unbiased estimates of the fold change (1.0003, 0.9994, 1.0008). However, in 
setting B, the normalized sample mean method overestimated the fold change (1.0094), 
and in setting C, the normalized sample mean method underestimated the fold change 
(0.9923). Compared to the normalized sample mean method, the normalized sample 
median method provided unbiased and efficient mean estimates (smaller MSE) in all five 
settings. However, the fold changes estimated in the normalized sample median method 
were unbiased but inefficient (larger MSE). The performance of the joint spatial Poisson 
model and the ICAR spatial Poisson model were similar. The two spatial Poisson models 
provided more efficient estimates (smaller MSE) of the expression level and the fold 
change compared to the normalized sample mean method and the normalized sample 
median method. 
4.3.2 Adding GC content as systematic bias 
 We observed a quadratic pattern between GC content and sequencing depth from 
an exploratory analysis of a real RNA-Seq dataset (appendix). It is challenging to 
measure the true underlying gene expression level with such systematic bias. To test the 
impact of GC content, we extended the previous simulation study be adding GC content 
as covariates in the mean structure. Here we compared four methods: the joint spatial 
Poisson model with GC content as covariates (Joint_GC), the ICAR spatial Poisson 
model with GC content as covariates (ICAR_GC), the normalized sample mean method 
(mean) and the normalized sample median method (median). 
 We first simulated seven cases and seven controls from the joint spatial Poisson 
regression model separately: 







 In this model,  is the GC content at the  th base, and  is the average GC 
content in this specified exon. We simulated   from a normal distribution with mean 
0.5373 and standard error 0.1197. These two values are calculated from the real data.  (see 
preliminary analysis of a real RNA-Seq data in appendix). Note that the GC content is the 
same at the  th base across all duplicated samples. Further we need to specify parameters: 
, , , , , , , , ,  and . The same simulation setting was 
adopted here: ,  and the true fold change is . The 
variance of two random effects, , , ,  were also from Table 4.1. To mimic 
the real RNA-Seq data (see preliminary analysis of a real RNA-Seq dataset in appendix), 
we set , ,  and . Here we 
assumed that the true expression level  was the sequencing depth at some base with 
GC content . In the simulation, we adopted a quadratic function form between GC 
content and sequencing depth, therefore the sequencing depth at most of the bases will be 
smaller than , and both the normalized sample mean method and the normalized 
sample median method underestimated the true expression level. Such bias was larger in 
controls than in cases since the coefficient ( ) of second order term  in the 
controls was smaller than those ( ) in the cases. As a consequence, both the normalized 
sample mean method and the normalized sample median method overestimated the true 
fold change. We used the same approach as the previous simulation study to record the 




values in Table 4.3 are the mean estimate and the mean square error (MSE) across 100 
simulations.  
 
Table 4.3 Simulation results when there is systemic bias. Best methods (smallest MSE) in 
each setting are listed in bold font.  
 
Settings 
Case Control Fold change 
Estimate MSE Estimate MSE Estimate MSE 
A 
Joint_GC 0.9993  0.0002  1.0019  0.0002  0.9976  0.0006  
ICAR_GC 0.9944  0.0004  1.0006  0.0004  0.9942  0.0007  
Mean 0.9838  0.0007  0.9528  0.0027  1.0328  0.0015  
Median 0.9639  0.0037  0.9550  0.0038  1.0098  0.0018  
B 
Joint_GC 1.0054  0.0003  1.0036  0.0003  1.0020  0.0005  
ICAR_GC 1.0005  0.0006  0.9955  0.0003  1.0053  0.0008  
Mean 0.9951  0.0005  0.9578  0.0023  1.0392  0.0021  
Median 0.9646  0.0030  0.9620  0.0030  1.0034  0.0017  
C 
Joint_GC 1.0035  0.0003  0.9999  0.0004  1.0040  0.0007  
ICAR_GC 1.0017  0.0004  0.9987  0.0008  1.0036  0.0010  
Mean 0.9880  0.0006  0.9648  0.0017  1.0242  0.0010  
Median 0.9760  0.0021  0.9430  0.0046  1.0357  0.0029  
D 
Joint_GC 1.0020  0.0004  1.0033  0.0004  0.9990  0.0007  
ICAR_GC 1.0007  0.0006  0.9999  0.0004  1.0011  0.0009  
Mean 0.9908  0.0005  0.9567  0.0022  1.0358  0.0017  
Median 0.9657  0.0031  0.9516  0.0037  1.0156  0.0026  
E 
Joint_GC 1.0022  0.0003  1.0015  0.0003  1.0009  0.0006  
ICAR_GC 0.9988  0.0005  1.0024  0.0006  0.9971  0.0012  
Mean 0.9915  0.0005  0.9603  0.0019  1.0326  0.0014  
Median 0.9620  0.0032  0.9530  0.0035  1.0101  0.0019  
 
 We observed that both the normalized sample mean method and the normalized 
sample median method underestimated the expression level of the cases and the controls 
in all five settings. In addition, both the normalized sample mean method and the 




With GC content as covariates, in all five settings both the joint spatial Poisson model 
and the ICAR spatial Poisson model provided more efficient estimate (smaller MSE) of 
expression level of the cases and controls, and the corresponding fold change. Further, 
the joint spatial Poisson model was better than the ICAR spatial Poisson model in terms 
of MSE. That was what we expected since the datasets were simulated from the joint 
spatial Poisson model. 
 In the joint spatial Poisson model with GC content as covariates (Joint_GC) and 
the ICAR spatial Poisson model with GC content as covariates (ICAR_GC), we can 
obtain the estimate of GC content effects. To compare these two methods, we also 
recorded the bias and the mean square error (MSE) of , ,  and  across 100 
simulations in Table 4.4. 
 The joint spatial Poisson model with GC content as covariates (Joint_GC) 
provided more efficient estimates (smaller MSE) of GC content effects than the ICAR 





Table 4.4 Bias and MSE of GC content effects 
 
Settings Methods 
    
Bias MSE Bias MSE Bias MSE Bias MSE 
A 
Joint_GC -0.0389 0.0708 0.0808 1.2813 -0.0375 0.0565 -0.0526 1.0827 
ICAR_GC -0.5335 0.5996 0.4426 2.3226 -0.4451 0.4779 0.0088 2.3588 
B 
Joint_GC -0.0544 0.0701 -0.2492 1.6509 0.0073 0.0787 -0.2457 1.4625 
ICAR_GC -0.5152 0.5852 0.0534 2.9662 -0.4057 0.4626 0.3396 1.7157 
C 
Joint_GC 0.0103 0.0767 -0.2067 1.3550 -0.0218 0.0868 0.0890 2.0289 
ICAR_GC -0.3835 0.4905 -0.0727 1.8915 -0.5484 0.6385 0.1682 4.0081 
D 
Joint_GC 0.0281 0.1028 -0.1476 2.0763 -0.0371 0.0803 -0.2386 1.8750 
ICAR_GC -0.4127 0.4854 -0.0727 3.3440 -0.4287 0.4698 0.0115 2.1239 
E 
Joint_GC -0.0548 0.0874 -0.1105 1.7161 -0.0391 0.0773 -0.0785 1.4506 





4.4 Real data analysis 
 In this study we analyzed the sequencing quality control project (SEQC) dataset 
(unpublished data from Dr Jun Li, Department of Human Genetics, University of 
Michigan), which consists of two samples from microarray quality control project 
(MAQC) (125): brain and universal human reference (UHR). They were prepared using 
the standard Illumina mRNA-Seq protocol and reagents and sequenced across seven 
lanes (across two single flowcells) to a depth of 35 bases. The data were generated using 
Illumina pipeline 1.1 and eland_rna which is optimized for alignment of transcriptomic 
reads. Only reads that uniquely mapped to the human reference genome, with up to two 
mismatches, were included in this study. Total numbers of uniquely mapped reads are 
listed in Table 4.5 (Lane 5 was used as the negative control).  
 
Table 4.5 Total numbers of uniquely mapped reads in the SEQC dataset 
 
Lane Brain (million) UHR (million) 
Lane 1 5.4285 6.5531 
Lane 2 6.3744 6.6063 
Lane 3 6.4921 7.2336 
Lane 4 6.6011 7.1439 
Lane 6 6.6963 7.0093 
Lane 7 6.5739 6.8177 
Lane 8 6.1030 6.4989 
  
 Exon level annotations for 385,122 ENSEMBL exons were downloaded from 
ENSEMBL database version 55: http://jul2009.archive.ensembl.org/biomart/martview/ 
with genome assembly GRCh37. Using UCSC genome browser tool ―liftover‖ to convert 




level sequencing depth files were generated for these 384,763 exons in seven brain 
samples and seven UHR samples.  
 Three exon filters were adopted in this study (Table A4.1 in appendix). The first 
one was the non-zero filter. First we removed all exons with zero sequencing depth since 
they contained no information. 170,877 exons left in the brain samples, 185,253 exons 
left in the UHR samples. The second one was the over-dispersion filter. The observed 
sequencing depth files exhibited substantial over-dispersion (Figures A4.1 in appendix): 
the variance of the number of reads in each exon is larger than the mean of the number of 
reads in each exon in the majority of exons with non-zero read coverage. We measured 
such over-dispersion in a specified exon by the test statistic proposed in Dean (1992) 
(126): 
  (4.12) 
 Here  is an index for the experimental conditions:  indicates the brain 
samples, and  indicates the UHR samples.  is an index for base, and  is 
the length of the specified exon.  is an index for sample, and  is the 
number of duplicated samples. Under  when  was generated from a Poisson 
distribution,  followed the standard normal distribution. Using the over-dispersion 
filter, we selected a subset of over-dispersed exons (  in all seven brain samples 
and  in all seven UHR samples). After this filtering, 43,141 exons were left in 
the brain samples and 56,947 exons were left in the UHR samples. The third one was the 
―non-gap‖ filter. Ideally, we expected that the sequencing depth would be constant within 




preliminary analysis of a real RNA-Seq dataset in appendix). Such gaps may be due to 
low overall sequencing depth, repeated regions, or inaccurate exon annotations. To avoid 
such complicating issues, we adopted a very stringent ―non-gap‖ filter in this study by 
defining ―non-gap‖ exons as those exons without gaps in either one of seven samples. 
3,569 ―non-gap‖ over-dispersed exons in brain samples and 5,241 ―non-gap‖ over-
dispersed exons in UHR samples were left after the three filters. 
 Three methods, the normalized sample mean method, the joint spatial Poisson 
model without GC content as covariates and the joint spatial Poisson model with GC 
content as covariates, were used to measure the exon level gene expression in 3,569 
exons in the brain samples and 5,241 exons in the UHR samples. The three methods were 
referred to as mean, noGC and GC in the following tables (Table 4.6, 4.7, 4.8, 4.9 and 
4.10), respectively. Due to the intensive computation, we used one chain in each Gibbs 
sample with 1,000 iterations. The first 900 samples were dropped as the burn- in stage, 
and then every 10th sample in the last 100 samples were used to calculate the posterior 
mean.  
 We compared the RNA-Seq data with the exon array data. The exon array data 
(127) was download from the NCBI Gene Expression Omnibus (GEO) repository under 
the GEO records GSE13072. Affymetrix GeneChip Human Exon 1.0 ST arrays were 
used to measure the brain samples and the UHR samples. There were ten brain samples 
and ten UHR samples, respectively. The custom CDF (128) file was used to process the 
raw CEL files, and then we obtained the exon level gene expression data for 304,495 
ENSEMBL exons. Merging the RNA-Seq data with the exon array data, 3,175 exons in 




 We used the exon array data as the gold standard, and compared the three 
methods: mean, noGC and GC, by Spearman’s rank correlation coefficients (Table 4.6). 
The overall performances were very similar. The normalized sample mean method was 
the best, while the joint spatial Poisson model with GC content as covariates was slightly 
better than the joint spatial Poisson model without GC content as covariates. 
 
Table 4.6 Spearman’s rank correlation coefficients for three methods 
Sample No. of exons Mean noGC GC 
Brain 3,175 0.4976 0.4915 0.4954 
UHR 4,499 0.4579 0.4523 0.4550 
  
 Inspired by the ideas in Li et al (129), we looked into the reason why our spatial 
Poisson models failed to provide more accurate exon level gene expression estimates. We 
believe that in most of the exons we compared, the three estimates were very similar. 
Therefore there was little improvement in the overall Spearman’s rank correlation 
coefficients. To see whether the joint spatial Poisson model can lead to improvement in 
those cases when it was different from the normalized sample mean method, we defined 
the distance  as the absolute log fold change between the normalized sample mean 
method and the joint spatial Poisson model with GC content as covariates:  
  (4.13) 
 The distance  can quantify the difference between the estimates from the 
normalized sample mean method and from the joint spatial Poisson model with GC 
content as covariates. We further classified all exons into four groups according to , and 





Table 4.7 Spearman’s rank correlation coefficients for three methods at difference  levels. 
 
Sample Distance # of exons Mean noGC GC noGC_Mean1 GC_Mean2 GC_noGC3 
Brain 
d>0.04 34 0.3553 0.4874 0.4933 37.17% 38.76% 1.16% 
d>0.03 113 0.2397 0.2689 0.2745 12.17% 14.52% 2.09% 
d>0.02 455 0.4962 0.506 0.5099 1.99% 2.76% 0.76% 
d>0.01 1531 0.4904 0.4871 0.4932 -0.66% 0.54% 1.21% 
UHR 
d>0.04 50 0.5138 0.5408 0.5636 5.25% 9.69% 4.22% 
d>0.03 169 0.3188 0.3222 0.3419 1.07% 7.26% 6.13% 
d>0.02 692 0.4921 0.4918 0.5042 -0.03% 2.50% 2.53% 
d>0.01 2310 0.4956 0.4937 0.4957 -0.39% 0.03% 0.42% 
 
1noGC_Mean: relative improvement between the joint spatial Poisson model without GC content as covariates and the normalized 
sample mean method. 
2GC_Mean: relative improvement between the joint spatial Poisson model with GC content as covariates and the normalized sample 
mean method. 
3GC_noGC: relative improvement between the joint spatial Poisson model with GC content as covariates and the joint spatial Poisson 




 From the Table 4.7, we found that the joint spatial Poisson model achieved high 
improvement when the estimates from the joint spatial Poisson model and the estimates 
from the normalized sample mean method were different. When the distance  was large 
than 0.04, using the joint spatial Poisson model with GC content as covariates provided 
38.76% relative improvement in the brain samples and 9.69% relative improvement in 
the UHR samples, in term of the Spearman’s rank correlation coe fficients. The relative 
improvement became smaller when the difference  were smaller. In addition, we found 
that using GC content as covariates was consistently better than without GC content.  
 To further investigate the benefit of modeling GC content, we quantified the 
difference between the joint spatial Poisson model with GC content and the joint spatial 
Poisson model without GC content by the distance : the absolute log fold change 
between two joint spatial Poisson models:  
  (4.14) 
 The distance  quantified the difference between two joint spatial Poisson 
models. We further classified all exons into four groups according to their distance , 
and then compared the performance of two joint spatial Poisson models within each 
group (Table 4.8). 
 We found that using GC content as covariates was consistently better than without 
GC content, especially when the difference between two methods was large. When the 
distance  was large than 0.03, using the joint spatial Poisson model with GC content 




relative improvement in the UHR samples, in term of the Spearman’s rank correlation 
coefficients. 
 
Table 4.8: Spearman’s rank correlation coefficients for two joint spatial Poisson models 
at difference  levels. 
 
Sample Distance # of exons noGC GC GC_noGC1 
Brain 
 88 0.2835 0.3161 11.52% 
 301 0.4199 0.4284 2.02% 
 1248 0.4476 0.4530 1.21% 
UHR 
 151 0.3477 0.3605 3.69% 
 505 0.3630 0.3669 1.06% 
 1795 0.4035 0.4079 1.09% 
 
1GC_noGC: relative improvement between the joint spatial Poisson model with GC 




 The recent arrival of next generation sequencing technologies is rapidly changing 
how we design future genetics and genomics studies (130,131). Compared to Sanger 
sequencing, these ―next generation‖ methods can produce orders of magnitude more data, 
and can do so efficiently, accurately, and at a fraction of the cost. These attractive 
features motivate scientists to apply these sequencing technologies to a variety of 
applications. One of the successful applications is the transcriptome analysis or RNA-Seq 
(104,107). Compared to microarray, RNA-Seq offers clear advantages such as better 
dynamic range and ability to discover novel transcript. However, just like in the early 




levels from the counts of sequencing reads. Current methods enumerate the number of 
reads landed within each exons and use the normalized read counts to represent the gene 
expression levels for that exon. However, the sequencing depth across exons varies 
substantially. The variation also differs across exons which will affect the simple 
enumeration method that is currently being used.  
 In microarray data analysis, estimates from parametric models such as the model-
based expression index (MBEI) from dChip (111) proved to be much more accurate in 
reflecting the underlying expression levels than summary statistics of raw intensity values. 
In this study, borrowing the idea from model-based methods for analyzing microarray 
data, we develop model-based methods to analyze base- level sequencing depth data from 
RNA-Seq for each exon using spatial Poisson regression models. First we introduce two 
random effects for spatial correlation and non-spatial variation. In addition, we observe a 
quadratic GC content effect on sequencing depth, and add both linear and quadratic terms 
of GC content in the mean structure of the spatial Poisson regression models. Both 
simulation studies and real data analyses demonstrate that the expression index estimated 
from spatial Poisson regression models reflect the underlying expression levels more 
accurately, compared to existing methods that enumerate reads within each exon.  
 In this study, we propose spatial Poisson regression models for the exon level 
RNA-Seq data. It is easy to extend these models to isoform level and gene level RNA-
Seq data. Since exons are nested within an isoform, one intuitive approach is to introduce 
a hierarchical structure into the models and model the spatial correlation between 
different exons within the same isoform. When there are multiple isoforms in a gene, 




these isoforms may also be different from each other. We can use a mixture of spatial 
Poisson models for gene level RNA-Seq data, and each spatial Poisson model will 
provide an isoform specific expression index. Further, the proportion of each isoform can 
be used to detect novel alternative splicing events.  
 We adopt three exon filters: non-zero filter, over-dispersion filter and non-gap 
filter in the real data analysis. It is reasonable to remove those exons without read 
coverage since there is no information for gene expression. Next, the spatial Poisson 
regression models implicitly assume that the observed exon level read counts to be over-
dispersed by modeling two random effects. Among all exons, a majority of them exhibit 
significant over-dispersion, and our spatial Poisson regression models are designed for 
those over-dispersed exons. For those exons without significant over-dispersion, the 
Poisson regression or other well tailored models could be better alternative solutions. In 
addition, we can remove the exon with gaps by using the non-gap filter. Lots of systemic 
biases will create gaps with exon and make real RNA-Seq data very noisy. Some gaps 
could be introns or intergenetic regions due to incorrect exon annotations. Further 
masked genomic regions or repeated regions can’t be mapped by short reads. The lowly 
expressed exons can’t be measured with limited sequencing depth. In this study, we use 
the stringent non-gap filter to avoid such potential systemic biases, but more 
sophisticated models, such as zero-inflated Poisson model (101) or generalized Poisson 
model (100), may fit well for read counts in exons with gaps. 
 Using exon array data as the gold standard for exon level gene expression may be 
not the best choice, since it is well-known that array-based technologies suffer from 




quantitative real-time PCR (qRT-PCR) (132) has been used as the gold standard to 
measure the fold change of gene expression between brain samples and universal human 
reference samples. Further study (132) showed that 3’ digital gene expression (DGE) data 
can provide high quality gene expression measurement. Using qRT-PCR and DGE data 
as the gold standard could be a good future direction. However, we only have gene level 
qRT-PCR and DGE data, the exon level qRT-PCR or DGE data is not available. 
Furthermore, it is challenging to directly compare them with RNA-Seq data due to 
alternative splicing. 
 There are still some limitations in the current work. First, the number of iterations 
used in the simulation study and real data analysis may not be large enough, and may 
result in biased estimates. Our spatial-based method is computational intensive compared 
to existing methods for analyzing RNA-Seq data. But since the same procedure is applied 
to each exon, the inference procedure can be run in parallel. We anticipate modern cluster 
computers will mitigate the computation burden we faced, especially with the massively 
parallel graphical processing unit (GPU) technology. We also believe that the accuracy in 
statistical inference outweighs computation cost. In addition, it is important to test the 
goodness of fit of our spatial-based method. Gelfand, Dey and Chang  proposed a model 
determination approach using predictive distributions (133), and we will include this in 





4.6.1 Formulas used in the MCMC algorithm 
4.6.1.1 Joint spatial Poisson regression model 
 Assume we have RNA-Seq data for a specific exon with length . Let  
represent the sequencing depth (number of mapped reads) at the  the base of a specified 
exon in the  th sample in a study. Here , and  is the length of the exon; 
, and  is the number of replicated samples. There are many factors, both 
biological and technological, that affect  including: (1) biological factors, for example, 
GC content, labeled by . (2) A random effect term to account for structure or spatial 
variability, denoted by . (3) A random effect term to account for unstructured, non-
spatial variability, denoted by . We propose the following spatial Poisson regression 
model for RNA-Seq data of a fixed exon: 
 
For the  th sample, we assume  follow a multivariate normal distribution with mean 
 and variance matrix , such that  and . The 
determinant and inverse of variance matrix  are: 
 
Where  is a 3-banded matrix: ; ; 
; . In addition, we assume  are independent 
and follow . We adopt a Bayesian approach, and assign conjugate prior to some 


























































For the  th sample,  
 
 









For  th base in the  th sample,  
 
 In each iteration of Gibbs Sampler, we will go through , , , , , 
,  and , and sample each 
parameter from its conditional distribution. For  and , we can directly 
sample from Gamma distribution. For , ,  and 
, we use adaptive rejection sample (ARS) since their conditional 
distributions are log-concave. For  and , we use adaptive rejection Metropolis sample 
(ARMS) since their conditional distributions are close to log-concave. 
4.6.1.2 ICAR spatial Poisson regression model 
 An alternative is to use ICAR prior for the random effects , and then the model 
is referred as the ICAR model.  


























For the  th sample,  
 
 









For  th base in the  th sample,  
 
 In each iteration of the Gibbs sampler, we go through , , , , , 
 and , and sample each parameter 
from its conditional distribution. For  and , we can directly sample from 
a Gamma distribution. For , ,  and 
, we use adaptive rejection sample (ARS) since their conditional distributions are 
log-concave. For , we use adaptive rejection Metropolis sample (ARMS) since its 
conditional distribution is close to log-concave. 
4.6.2 Performance of the normalized sample mean method  
 Let  represent the sequencing depth at the  th base of a specified exon where 
, and  is the length of the exon; , and  is the 
number of duplicated samples. Here  is an index for the experimental conditions:  
indicates the case sample, and  indicates the control sample. We simulated seven 







In the normalized sample mean method, the estimates of exon level gene expression are: 
 
Which is an unbiased estimate of  
 
The moment estimate of fold change is: 
 
When the data  are simulated from the joint spatial Poisson model, the normalized 
sample mean method will always overestimate the true expression level. Larger total 
variance of two random effects indicates larger bias. However, the bias of fold change 
estimator is not simple. When the total variances of two random effects are the same in 
two experimental conditions , the estimate of fold change is 
unbiased. When the total variance of two random effects in case is larger than that in 
control , the estimate of fold change will overestimate the true 
value, while when the total variance of two random effects in case is smaller than that in 
control , the estimate of fold change will underestimate the true 
value. To account for these complicated cases, we considered five different cases for 
variance of the two random effects (Table 4.1). 
4.6.3 Preliminary analysis of a real RNA-Seq dataset 
 In this study we analyzed the sequencing quality control project (SEQC) dataset 
(unpublished data from Dr Jun Li, Department of Human Genetics, University of 
Michigan), which consists of two samples from microarray quality control project 




the standard Illumina mRNA-Seq protocol and reagents and sequenced across seven 
lanes (across two single flowcells) to a depth of 35 bases. The data were generated using 
Illumina pipeline 1.1 and eland_rna which is optimized for alignment of transcriptomic 
reads. Only reads that uniquely mapped to the human reference genome, with up to two 
mismatches, were included in this study.  Exon level annotations for 385,122 ENSEMBL 
exons were downloaded from ENSEMBL database version 55: 
http://jul2009.archive.ensembl.org/biomart/martview/ with genome assembly GRCh37. 
Using UCSC genome browser tool ―liftover‖ to convert GRCh37 to NCBI36, total 
number of exons was reduced to 384,763, and then the base- level sequencing depth files 
were generated for these 384,763 exons in seven brain samples and seven UHR samples. 
We applied three exon filters in this study: non-zero filter, over-dispersion filter and non-
gap filter. The number of exons left in the brain samples and the UHR samples are listed 
in Table A4.1. 
 
Table A4.1: The number of exons left in the brain samples and the UHR samples after 
three exon filters 
Filters Brain UHR 
Total number of exons 384,763 384,763 
After non-zero filter 170,877 185,253 
After over-dispersion filter 43,141 56,947 
After non-gap filter 3,569 5,241 
  
 We plotted the Log2 RPKM versus the Log2 variance for 170,877 non-zero exons 
in seven brain samples and 185,253 non-zero exons in seven UHR samples in Figure 




number of reads in each exon is larger than the mean of the number of reads in each exon 
in the majority of non-zero exons, especially for the highly expressed exons.  
 
Figure A4.1: Log2 RPKM versus Log2 variance in all 14 samples. The red line is the 

















 Next we explored the correlation between GC content and sequencing depth. We 
divided each of these 384,763 exons into 100 bp bins, and counted the number of ―G‖ 
and ―C‖ in each bin. The GC content is defined as the sum of the ―G‖ count and the ―C‖ 
count. The average length of these 384,763 exons is 293 bp. We removed the bins with 
length less than 100 bp, and then got 912,929 100 bp bins. Then we calculated the 
number of mapped reads in each 100 bp bin, and removed the bins with zero read 
coverage. The total number of 100 bp bins was reduced to 297,404. The distribution of 
GC content in these 297,404 100 bp bins looked similar to normal distribution (Figure 











Figure A4.2: Distribution of GC content in 297,404 100 bp bins 
 
 Next we calculated the Log2 RPKM (reads per thousand base pair per million 
uniquely mapped reads) for each of these 297,404 100 bp bins in each sample, and then 
took the average of Log2 RPKM across the 100 bp bins with the same GC content. 
Figure A4.3 shows the quadratic patterns between GC content and Log2 RPKM in seven 
brain samples and seven UHR samples.  
 
Figure A4.3: Quadratic patterns between GC content and Log2 RPKM in seven brain 





 From Figure A4.3, we observed a quadratic pattern between GC content and Log2 
RPKM: the bins with small or large GC content have lower sequencing depth than the 
bins with median GC content, except for the noise at the two edges (number of GC < 20 
and numebr of GC > 90) which may due to lack of sample size. In addition, the within 
sample variation is very small, but there may exist some between sample variation.  
 Next we took average of Log2 RPKM with same GC content across seven 
duplicated samples in brain or UHR, and then fitted a simple weighted linear regression 
with quadratic term. The weight is the frequency of GC content (Figure A4.2). We 
assumed that the bin with GC content 50 has Log2 RPKM zero. The normalized GC% 
was defined as:  
 
Figure A4.4 shows the raw data and the fitted lines from the simple linear regression.  
For brain samples: 
 













Figure A4.4: Simple weighted linear regression with quadratic term 
 
To incorporate GC content as covariates, we add both linear and quadratic term of GC 
conent:  
 
Where  represent the fixed effect of GC content, ’s are the 
random effect for the spatial correlation, and ’s are the random effect for unstructured 
variability. Assume the reads is 35 bp. We extend the  th base to both sides for 34 bp to 
make a 69 bp bin, and then define  as the percentage of ―G‖ and ―C‖ in this 69 bp bin 
centered at the  th base.  is defined as the mean percentage of ―G‖ and ―C‖ in the 
specified exon.  is the exon level expression index for the  th sample with GC content 
, which is the parameter of interest. Note that we observed very little within sample 
variation, therefore the parameters  and  are the same across all  duplicated samples.  
 We draw trace plots (Figure A4.5) for the exon ENSE00001701801 (chr 17, 
1250091~1250306) from seven brain samples. It contains 216 bases, and shows 




Figure A4.5: Trace plots for the exon ENSE00001701801 
 
Table A4.2: Mean, variance and ACF for exon ENSE00001701801 in seven brain 
samples 
 
Lane Mean Variance ACF(lag=1) ACF(lag=20) 
1 58 2068 0.9893  0.7095  
2 64 2852 0.9903  0.6811  
3 61 2489 0.9896  0.6736  
4 74 3417 0.9878  0.6967  
6 62 2581 0.9904  0.6773  
7 71 3258 0.9902  0.6867  









 This thesis presented model-based methods for the analysis of high throughput 
genomic data. In the presence of technologically specific features, heterogeneous data 
structures and massive sample sizes, Bayesian approaches can be a powerful modeling 
framework. The research in this dissertation demonstrates that Bayesian modeling 
approaches have achieved great success and have the potential to accelerate biomedical 
research. 
 Chapter 2 describes a model-based Bayesian variable selection approach to query 
large scale microarray compendium datasets. By modeling the observed microarray 
compendium data as a mixture of normal distributions, this approach identifies transcript 
factor target genes under a subset of experimental conditions. Further, it is capable of 
detecting complicated co-expression patterns, such as inversed patterns, and it is robust in 
the presence of sporadic outliers. All these unique features are critical to improve the 
power of differentiating biological signals from background noise. Due to the high 




estimate is not feasible. In this context, a Bayesian modeling approach coupled with 
Markov Chain Monte Carlo estimation techniques appears to be an attractive alternative. 
 Chapter 3 presents hybrid motif sampler (HMS), a de novo motif finding 
algorithm designed for analyzing ChIP-Seq data. We model the intra-motif dependency 
using high dimensional multinomial distributions. The increased number of model 
parameters is supported by the dramatically increased sample size in ChIP-Seq 
experiments and describes the underlying motif pattern more accurately. Borrowing 
information from the base level sequencing depth data, we adopt an informative prior 
distribution to facilitate motif detection. We also combine stochastic sampling and a 
deterministic search to speed up the computationally intensive iterative procedure. Using 
a Bayesian modeling approach to analyze ChIP-Seq data thoroughly and efficiently will 
significantly improve the accuracy of existing transcript factor binding sites.  
 Chapter 4 introduces a spatial Poisson regression model for exon level RNA-Seq 
data. We utilize two random effects to explain the spatial correlation and the non-spatial 
variation. These two random effects are not directly observable. We need to use high 
dimensional integration to integrate them out in frequentist methods. Bayesian modeling 
with Markov chain Monte Carlo techniques provides an appealing solution by iteratively 
sampling each random effect from conditional distributions. We also incorporate GC 
content effects into the mean structure for better fitting, and it can be easily extended to 
adjust for other biological effects and technical effects. The analysis of the SEQC dataset 
shows that the spatial Poisson regression model has the ability to improve quantification 




 In all chapters, the Bayesian modeling framework serves as the consistent 
procedure for combining information from high throughput genomic data and prior 
information. The fast and efficient Markov Chain Monte Carlo techniques allow 
statistical inference despite of the high dimensionality of unknown parameters. With the 
development of new biological technologies, scientists are facing an analytic bottleneck 
of accumulating high throughput genomic data. Therefore, Bayesian modeling 
approaches will be of greatest benefit to the broader biomedical community for their 
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